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ABSTRACT 
 
 
Tight junctions (TJ) constitute the primary component of epithelial barrier 
function, a disruption of which is involved in the pathogenesis of many gastrointestinal, 
pulmonary and renal diseases. Occludin is the major transmembrane protein of TJ, a 
deletion of which leads to a complex phenotype including chronic inflammation in 
several epithelial tissues of occludin deficient mice and poor TJ integrity in epithelial cell 
lines. Its down regulation was seen in Crohn’s disease, tumors of the colon, brain, 
endometrium and breast cancer. Occludin is also known to be a target that enables 
Hepatitis C Virus infection and bacterial pathogenesis. But the specific function of 
occludin in TJ remains unknown. Numerous studies implicated that occludin 
phosphorylation plays a crucial role in TJ regulation. Based on our previous studies, we 
have identified a conserved phosphorylation hotspot in the C-terminal domain of 
occludin, called occludin regulatory motif (ORM), which has a potential to confer 
dynamic properties to occludin. The present study was designed to determine the function 
of ORM in TJ regulation.  
 
Stable, occludin-deficient MDCK cell line (OD-MDCK) that expresses wild type 
occludin (OclWT) or a deletion mutant occludin (OclDM) that lacked ORM were 
developed. Confocal imaging and immunoprecipitation analyses showed that absence of 
ORM does not prevent occludin localization and interaction with ZO-1 at TJ. However, 
FRAP analysis showed that mobile fraction of occludin is reduced by the absence of 
ORM, suggesting the role of ORM in occludin dynamics. Also, Ca2+ depletion-induced 
disruption of TJ, adherens junctions and cytoskeleton and barrier dysfunction were 
attenuated in the absence of ORM. Mutation anlaysis of ORM phosphosites Y 398, Y 
402, T403 and T404, revealed that ORM-mediated phosphorylation events determine the 
dynamic properties of TJ. Then the role of ORM-mediated protein interactions in TJ 
modulation was investigated. A synthetic peptide analogous to occludin regulatory region 
(ORP), which enhanced TJ assembly and attenuated radiation-induced barrier 
dysfunction in Caco-2 cells, was used as bait to pull down proteins that interact with 
ORM. Proteomic analyses and pull down assays using ORP and GST tagged occludin C-
terminus identified that MAP7 (an epithelial specific microtubule associated protein) 
interacts with ORM in a tyrosine phosphorylation-dependent mechanism. Furthermore, 
MAP7 binding to occludin in Caco-2 cells was elevated by treatment with osmotic stress 
or dextran sodium sulfate, both known to increase occludin Tyr-phosphorylation. These 
data demonstrated that MAP7 interacts with ORM and mediates occludin redistribution 
during TJ disruption.  
 
In conclusion, ORM confers dynamic properties to TJ via its phosphorylation 
dependent protein-protein interactions. The findings in my project establish the functional 
significance of ORM in TJ dynamics and regulatory mechanisms associated with TJ 
modulation. Identification of proteins that interact with ORM provides new therapeutic 
targets in the treatment of diseases associated with occludin depletion and epithelial 
barrier dysfunction.   
 vi 
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CHAPTER 1.    INTRODUCTION 
 
 
Epithelial Tight Junctions  
 
Luminal and vascular fluid spaces are delimited by epithelial and endothelial 
barriers. The characteristic property of forming a barrier between external and internal 
milieu that generates and maintains physiological functioning of compartments is mainly 
attributed to the intercellular junctions. These include tight junctions (TJ; also Zonula 
occludens), adherens junctions (Zonula adhaerens), desmosomes (macula adhaerens) and 
gap junctions (Figure 1-1A).  
 
Tight junctions (TJ), originally identified by Farquhar and Palade in the early 
1960s, are the most apical sites of cell-cell contact (1). On a freeze-fracture micrograph, 
TJ appear as a belt-like ring of continuous anastomosing strands sealing and eliminating 
the intercellular space (Figure 1-1B) (2). This led to the early belief that TJ form an inert 
and impervious barrier, which later was disproved as TJ components have now been 
identified to be under continuous remodeling at steady state (3). TJ do not seal the 
paracellular space completely but regulate the paracellular transport of solutes based on 
charge and size. Modulation of barrier properties of TJ in response to physiological, 
pharmacological and pathological stimuli has been demonstrated in several studies (4-9). 
 
 
Physiological Functions of TJ 
 
Epithelial TJ serve two main functions: a “gate function” where the TJ strands 
from neighboring plasma membranes associate with each other and provide selective 
permeability to ions, water and solutes through paracellular diffusion and a “fence 
function” that prevents intramembrane diffusion of proteins and thus confers polarity to 
cells (10,11). Besides their role in these classical functions, several studies reported that 
TJ play an important role in signal transduction (12-14).  
 
 
Early Discovery of TJ Components 
 
The first component of TJ was discovered in 1986 in mammalian epithelial and 
endothelial cells and named as Zonula occludens-1 (ZO-1; 225 kDa) (15). The next TJ 
associated protein called Cingulin (160kD) was discovered in in 1988, in avian brush-
border cells (16). Both of these are not integral membrane proteins and the search for 
membrane associated TJ components continued. Occludin (65 kD) was the first integral 
membrane protein of the TJ to be discovered by Furuse et al in 1993 (17). Occludin is a 
tetra spanning membrane component of the TJ strands, which interacts with ZO-1 and 
confers adhesive properties to cells (18,19).  Then another class of transmembrane 
proteins with no sequence similarity and phylogenetically unrelated to occludin called 
claudins (21-34 kD) were discovered in 1988 (20). Claudin family of proteins includes 
nearly 27 members, mutations of which cause hereditary diseases (21).   
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Figure 1-1. Intercellular Apical Junctional Complex and Tight Junctions. 
 
A. Schematic shows intercellular junctions between intestinal epithelial cells. B. Electron 
micrograph of mouse intestinal epithelial cells shows intercellular junctions. Inset shows 
freeze fracture micrograph of tight junctions as continuous anastamosing strands present 
at the apical end. Scale bar is 200nm. (Mv, microvilli; TJ, tight junction; AJ, adherens 
junction; DS, Desmosome; Ap, apical membrane; Bl, basolateral membrane).  
Source: Reprinted by permission from Macmillan Publishers Ltd: Tsukita, S., Furuse, M., 
and Itoh, M. (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2, 
285-293. Copyright © 2001.   
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Characteristics of TJ 
 
 
Electrical Resistance 
 
The two-membrane model suggested that apical and basal membranes differ in 
their conductance properties. Sodium passes across the apical membrane via the Na 
channels into the cells down its concentration gradient, while it is pumped across the 
basolateral membrane via energy dependent Na,K-ATPase. The shunt pathway suggested 
that this electrical gradient generated by the active transport of Na+ leads to passive 
diffusion of Cl- ions through the paracellular route. This revealed that the transcellular 
and paracellular transport are physiologically coupled.  
 
Transporters in the apical and basolateral membranes mediate transcellular 
transport. According to the electrical circuit model, the series elements of the resistance 
of apical (Rapical) and basolateral (Rbasolateral) membranes are in parallel to the resistance of 
the TJ (RTJ). Because the resistance of cell membranes (Rapical and Rbasolateral) is usually 
high, it is the resistance of TJ (RTJ) that determines the transepithelial electrical resistance 
(TER). It is well accepted that the resistance differs significantly among various tissues 
and hence referred to as either “tight” or “leaky” epithelia. A good example of a leaky 
epithelium is that of the mammalian proximal tubule with TER ~6 Ω.cm2, and an 
example of a tight epithelium is that of a toad urinary bladder with TER ~300,000 Ω.cm2. 
The physiological significance of the differences in TER becomes evident when we look 
at the specific function of the epithelium. In the distal nephron, the “tight” TJ are 
responsible for maintaining high electrochemical gradient generated by the active 
transcellular transport. Except colon all the segments of gastrointestinal tract are leaky, as 
higher concentration gradients are to be maintained for reabsorption of NaCl and water 
and hence exhibit a higher resistance.  
 
In most cases, the tightness of the epithelia correlated with the number of TJ 
strands, where tight TJ had more than five strands while the leaky TJ had one single 
strand. Here it was believed that the resistance of each strand was in series with that of 
the other strands which is basically the sum of resistances of all the strands and hence has 
a linear relationship. This was not true in the case of two strains of MDCK, which 
exhibited several fold difference in TER although they had same number of TJ strands. 
 
 
Size and Charge Selectivity 
 
Another model suggested that TJ strands were assumed to be pores that can be 
open or closed. As TER is measured instantaneously, the resistance was believed to be 
proportional to the open probability of TJ pores raised to the negative power of number 
of TJ strands. But this could neither explain the paracellular charge selectivity of different 
epithelia nor the size selectivity within the same epithelium. It was seen that, along the 
crypt villus axis in rat jejunum, there was an apparent difference in size selectivity. The 
upper villus portion allows solutes of radii up to ~6 A0, the lower villus allows solutes of 
radii up to ~10 A0 while the crypt allows much larger solutes with radii up to ~60 A0. 
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Caco-2 cell line known to exhibit villous differentiation has been shown to have 3 distinct 
pathways similar to that of rat jejunum. These include one that allows passage of 
molecules with radii less than 4 A0, one that allows passage of molecules of radii 6.5 A0 
and one that allows paracellular transport of much larger non-charged molecules.  
 
 
Pore and Leak Pathways  
 
From several studies performed later on to characterize the size selectivity of 
different epithelia, it was discovered that the paracellular route of transport in itself has 
two distinct pathways referred to as pore and leak pathways. These two pathways 
together contribute to the gate function on the TJ. 
 
According to the two pathway model (21) (Figure 1-2), pore pathway is a high 
capacity, charge selective pathway that allows passage of small ions and solutes less than 
~4 A0 in size. Since this pathway is capable of ionic charge discrimination, it is 
responsible for carrying most of the electrical current during transport.  It is now known 
that a subset of claudins, have the capability to form pores that confer size and charge 
selectivity. It is the composition of claudins that determines the charge selectivity of the 
epithelial barrier. 
 
Leak pathway is a low and non-charge selective pathway that allows passage of 
larger solutes. Solutes larger than ~4 A0 in size are transported through the leak pathway. 
Flux studies using tracers like mannitol (4.2 A0) and inulin (15 A0 ) represents 
permeability through the leak pathway. It has been observed that the proinflammatory 
cytokines can increase flux through the leak pathway without altering the pore pathway. 
Regulation of this non-pore pathway is known to involve myosin light chain kinase 
activity and dynamics of cytoskeleton. 
 
 
Measurement of Electrical Resistance, Size and Charge Selectivity 
 
TER is a measure of the flux of all ions across the epithelium which is best 
represented in leaky epithelia where ion conductance across TJ is far greater than that of 
apical and basolateral membranes. Na+ and Cl- are the most common ions present in the 
physiological solutions and they do not discriminate between pore and leak pathways. 
Any change in either of the pathways reflects in TER. Hence TER cannot be used to 
study size and charge selectivity of the epithelium. 
 
Charge selectivity can be studied by dilution potential technique. Creating an 
electrochemical gradient by isosmotic alteration of NaCl concentration across the 
epithelium provides a new equilibrium potential now based on the relative permeability  
of Na+ and Cl− ions. Permeability ratio ranges from 10 to 0.1 in different epithelia. 
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Figure 1-2. Two-Pathway Model.  
 
Permeability of non-charged polyethylene glycol molecules of various sizes across an 
epithelium is plotted against their radius. The pathway for molecules smaller than 4 A0 in 
diameter, referred to as pore pathway, is dictated by size and charge selective claudins. 
The pathway for molecules larger than 4 A0 in diameter, referred to as a leak pathway, is 
not charge selective and is governed by the status of cell-cell adhesion and cytoskeleton. 
Source: Reprinted with permission. Anderson, J. M., and Van Itallie, C. M. (2009) 
Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 1, 
a002584. Copyright © 2009 Cold Spring Harbor Laboratory Press. 
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Bi-ionic substitution is a technique used to determine the charge selectivity of the 
barrier. This involves replacement of Na+ on one side of the epithelium with organic 
cations of various sizes, measuring the permeability of each organic cation, which in turn 
determines the size selectivity of pore pathway. Permeability through the leak pathway 
can be determined by measuring flux of large tracer molecules like mannitol, sucrose, 
and inulin. Polymers of varying sizes such as polyethylene glycols or dextrans are also 
widely used to determine paracellular permeability. 
 
 
Architecture of TJ 
 
The typical architecture of TJ involves integral membrane proteins of three major 
families: transmembrane associated marvel protein family (TAMP) comprising of 
occludin, tricellulin and marvel D3 (1), claudin family and immunoglobulin superfamily 
members such as junction adhesion molecules (JAMs) (8). A perijunctional actomyosin 
ring comprising of a thick band of actin and myosin II is present just below the TJ. The 
C-terminal domains of the integral proteins interact with intracellular PDZ-domain 
containing scaffolding proteins such as ZO-1, ZO-2 and ZO-3, which in turn crosslink 
membrane proteins with actin cytoskeleton (2-4) (Figure 1-3). TJ protein complex 
recruits classic-signaling molecules like PKCs, c-Src, c-Yes, PP2A, PP1 and transcription 
factors like ZONAB, thus forming a regulatory platform for mediating responses to 
extracellular and intracellular stimuli (14).  
 
 
TAMPS 
 
This family of TJ proteins includes occludin, tricellulin (also called MarvelD2) 
and Marvel D3. These proteins have a conserved MARVEL (MAL and related proteins 
for vesicle trafficking and membrane link) domain with four transmembrane domains 
linked by two extracellular (EL) loops and one intracellular loop (IL) (22). Occludin 
forms homophilic interactions at the bicellular junctions via its extracellular domains. 
Tricellulin is localized at tricellular junctions and is believed to form a barrier for macro 
molecules (23). MarvelD3 is mainly localized at the bicellular junctions and is not 
required for TJ formation (22). 
 
 
Claudins 
 
To date, this TJ protein family includes nearly 27 different claudins. Their domain 
structure includes an intracellular N-terminus, a longer C-terminus, two extracellular 
loops and an intracellular loop. The first extracellular loop consists of a signature 
sequence and a C-terminus PDZ domain-binding motif, which interacts with ZO-1. 
 
All claudins are barrier-forming proteins, however some claudins are considered 
to be pore-forming based on their ability to increase paracellular permeability specifically 
to molecules of certain size or charge but do not affect the barrier permeability to  
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Figure 1-3. Tight Junction- a Multi-protein Complex. 
 
Epithelial tight junctions comprise of integral transmembrane proteins such as occludin, 
claudins, and junction adhesion molecules (JAM) that seal the paracellular space. The 
intracellular tails of these membrane proteins interact with scaffolding proteins such as 
ZO-1, ZO-2, ZO-3 which then cross link membrane proteins with the actin cytoskeleton. 
Source: Reprinted with permission. Groschwitz, K. R., and Hogan, S. P. (2009) Intestinal 
barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 
124, 3-20. Copyright © 2009 American Academy of Allergy, Asthma & Immunology. 
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macromolecules. Claudin-2, -10b, 15 and 16 are known to be cationic pore forming 
claudins while claudin-10a and -17 are anionic pore forming claudins. Mutations in these 
genes are known to cause hereditary diseases (24). Claudin-2 is a well-studied cationic 
pore forming claudin that is highly expressed in leaky TJ like that of proximal tubule and 
intestinal crypts. In the proximal tubule, claudin-2 is responsible for passive reabsorption 
of sodium (25,26).  
 
 
Peripheral TJ Proteins 
 
The intracellular scaffolding proteins include zonula occludens proteins (ZO-1, 
ZO-2, ZO-3), MAGI proteins (MAGI1, MAGI2 and MAGI3), Par-3, Par-6, MUPP and 
PatJ. The ZO proteins belong to the MAGUK (membrane-associated guanylate kinase 
homologues) protein family as their domain composition includes 3 PDZ domains in the 
N-terminus, a SH3 homology domain and a guanylate kinase domain. The guanylate 
kinase domain of ZO-1 interacts with occludin c-terminus. Cingulin is associated with the 
cytoplasmic surface of TJ and expressed during early embryogenesis and epithelial 
maturation. Cingulin links TJ proteins to actin cytoskeleton via interactions with ZO 
proteins and actin. ZONAB. Rab13 (27). 
 
 
Occludin Structure 
 
Occludin is expressed in various epithelial cells but is not detectable in 
fibroblasts. Human occludin gene was mapped to chromosome band 5q.13.1. Nearly 90% 
homology exists among mammalian occludins (20). The multidomain tetra span structure 
includes four transmembrane domains (TM), two extracellular loops (EL1 & EL2), a 
cytoplasmic short N-terminus and an extended C-terminus. EL1 and EL2 are involved in 
cis and trans homophilic interactions (28). The coiled coil domain in occludin C-terminus 
interacts directly with the guanylate kinase-like (GUK) domain of ZO-1 (29). Nearly half 
of the 522 amino acid residues of occludin (266-522) are present in its C-terminus and is 
a known target for several kinases and phosphatases (30). Multiple bands of occludin are 
often detected by immunoblot analysis, which are believed to be phosphorylated forms of 
occludin. Most of the studies were performed using antibodies that detect occludin band 
around 65 kDa.  
 
 
Occludin C-terminus Harbors a Conserved Phosphorylation Hot Spot 
 
Structural analysis of occludin C-terminus (383-522) revealed that the distal part 
of this domain, comprising of amino acids from 416 to 522, is involved in an ordered 
coiled-coil structure that interacts with ZO-1 while the region comprising of N-terminus 
34 amino acids is disordered (31). This proximal disordered region includes a sequence 
of amino acids highly conserved among mammalian species. Most notably this includes a 
phosphorylation hotspot stretching from Y-398 to S-408.  
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Occludin Regulatory Motif (ORM) 
 
Previous studies showed that occludin undergoes tyrosine phosphorylation that 
regulates its interaction with ZO-1 during H2O2 induced TJ disruption (32,33). Elias et al 
highlighted the presence of a highly conserved phosphorylation hot spot (Y398-S408) in 
occludin C-terminus (Figure 1-4A) and identified that phosphorylation of Y-398 and Y-
402 attenuates its interaction with ZO-1 (34). Suzuki et al showed that PKCη mediated 
phosphorylation of T403 and T404 is involved in the regulation of epithelial TJ (35). It 
was believed that tyrosine phosphorylation (Y-398, Y-402) by c-Src, destabilizes TJ 
whereas threonine phosphorylation (T403, T404) by PKCζ and PKCη promotes TJ 
assembly (36). Studies by Turner group demonstrated the role of S408 phosphorylation in 
the regulation of barrier function (37). Later on, Dorfel et al showed that CK2-mediated 
serine/threonine phosphorylation of the T400-XXX-T404-XXX-S408 motif regulates TJ 
modulation (38). Although the structure of this phosphorylation hot spot (Y398-S408) 
was not resolved by crystallography, based on the observations that this region is a target 
for phosphorylation mediated TJ regulation, we considered this motif a functional 
component of occludin and coined the term “occludin regulatory motif” (ORM) (Figure 
1-4B). 
 
 
Occludin Function 
 
Overexpression of occludin in insect cells resulted in occludin localization at the 
intracellular multi-lamellar bodies similar to TJ (39). Expression of occludin in MDCK 
cells resulted in occludin localization at intercellular junctions with increased TER and 
increased paracellular permeability (40). Occludin expression in fibroblasts that are 
occludin deficient but express ZO-1 and AJ proteins, occludin was localized at cell-cell 
contacts and conferred cell adhesion (19). These data suggested that occludin is required 
for formation of TJ. However, alteration of both alleles of occludin in embryonic stem 
cells did not prevent formation of TJ strands, suggesting that other TJ associated proteins 
can form TJ strands even in the absence of occludin (41).  
 
Saitou et al generated occludin -/-mice that carried a null mutation in occludin 
gene, to study its function in vivo. The heterozygous and homozygous mutant mice were 
viable with no gross phenotype at birth but exhibited post-natal growth retardation. There 
were no significant changes in the formation of TJ strands (in terms of their number, size 
and appearance) in mutant mice compared to wild type mice, as visualized by ultrathin-
section electron microscopy and freeze fracture replica electron microscopy. TJ were 
similarly not affected in kidney or liver of the occludin -/- mice. TER of the small and 
large intestinal epithelial layers was low in mutant mice but not statistically significant. 
Histological examination revealed chronic inflammation and hyperplasia in occludin -/- 
mice. Calcification in the brain, thinning of the bone and male infertility were also 
observed in occludin -/- mice (42). These data together suggested that occludin gene is 
indispensable and the complex phenotype seen its absence is probably due to an 
unidentified function of occludin. 
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Figure 1-4. Conserved-phosphorylation Hot Spot in Occudin C-terminus. 
 
A. Sequence alignment of a portion of Occludin C-terminus showing highly conserved region among various species. B. Domain 
structure of occludin with two extracellular loops (EL1 & EL2), an intracellular loop (IL), four transmembrane domains(TM1-4), 
intracellular N and C-terminii. Distal region of occludin with phosphosites Y398-S408 is termed as occludin regulatory motif (ORM)  
Source: Reprinted with permission. Cummins, P. M. (2012). "Occludin: one protein, many forms." Mol Cell Biol 32(2): 242-250. 
Copyright © 2012, American Society for Microbiology. 
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Occludin was shown to form a complex with extrinsic death receptor and induce 
apoptosis in epithelial cells (43). Occludin downregulation by siRNA in human 
keratinocytes reduced cell-cell adhesion and susceptibility to apoptosis and altered Ca2+ 
homeostasis and cell differentiation (44). Occludin overexpression and knockdown 
altered TNF mediated changes in barrier function indicating that occludin is required for 
cytokine-mediated TJ regulation (45). 
 
 
TJ- a Dynamic Multi-Protein Complex at Steady State 
 
Studies by Turner group have demonstrated that the TJ multiprotein complex is 
highly dynamic at steady state. Extensive FRAP (Fluorescence recovery after 
photobleaching) based experiments were performed by Shen et al., in MDCK cell 
monolayers expressing EGFP tagged occludin/ZO-1/claudin-1/β-actin (3). Fluorescence 
recovery analyses of each of these proteins revealed that most of the TJ-associated 
occludin is highly mobile (mobile fraction 71±3%) with a slow exchange between 
bleached and fluorescent pools of occludin and a t1/2 of 194 ± 19s. ZO-1 mobility is 
similar to that occludin (mobile fraction 69±5%) but exchanges more rapidly than 
occludin with a t1/2 of 119 ± 21s. Although occludin interacts with ZO-1, these two TJ 
proteins do not exchange as a complex and have distinct dynamic behavior. On the other 
hand, claudin-1 has relatively low mobility (mobile fraction 71±3%) and hence only a 
small fraction of TJ associated claudin-1 is available for exchange. β-actin which is 
known to be highly dynamic, has a mobility that is higher than the three TJ proteins 
(mobile fraction 98±6%) and a t1/2 of 106 ± 18 (Table 1-1).  
 
 
Occludin Exchange Occurs by Diffusion within and Between TJ and Lateral 
Membrane 
 
In order to determine whether the diffusion during FRAP occurs within the 
membrane associated TJ or intracellular pools; further analyses by interfering with 
membrane fluidity, cellular ATP levels and vesicular transport were performed. Reducing 
the temperature of cell monolayers from 37°C to 14°C, reduced the mobility of occludin. 
This was due to the low temperature mediated stabilization of cholesterol rich TJ 
membrane domains. Because endocytosis of occludin was shown to be involved in 
cytokine mediated TJ regulation, it was believed that fluorescence recovery of occludin 
was mediated by vesicular transport. But neither ATP depletion, nor treatment with a 
guanine exchange factor inhibitor affected occludin kinetics, suggesting that occludin 
exchange does not involve vesicular transport. On the other hand, methyl-B-cyclodextrin 
(MDCD)-mediated cholesterol depletion blocked occludin fluorescence recovery. FLIP 
(Fluorescence loss in photobleaching) analysis was used to assess the exchange between 
morphologically distinct protein pools of the TJ. FLIP analyses showed that continuous 
photobleaching of cytoplasm did not affect fluorescence loss at TJ, but photobleaching at 
the TJ resulted in fluorescence loss in the regions adjacent to the photobleached region. 
These data together suggest that occludin fluorescence recovery is mediated by diffusion 
within the membrane and the membrane fluidity plays an important role in its mobility. 
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Table 1-1. Dynamic Behavior of TJ Proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Modified with permission. Shen, L., Weber, C. R., and Turner, J. R. (2008) The 
tight junction protein complex undergoes rapid and continuous molecular remodeling at 
steady state. J Cell Biol 181, 683-695. Copyright © 2008 Shen et al.  
  
TJ Protein Protein Pools Value (%) 
Occludin 
 
 
 
 
 
 
 
 
Tight junction 
-Mobile 
-Immobile 
 
Lateral membrane 
-Mobile 
-Immobile 
 
Intracellular 
80 
80 
0 
 
20 
20 
0 
 
0 
 
ZO-1 
 
 
 
 
 
 
 
Claudin-1 
 
 
 
 
 
 
 
Tight junction 
-Mobile 
-Immobile 
 
Lateral membrane 
 
Intracellular 
 
Tight junction 
-Mobile 
-Immobile 
 
Lateral membrane 
 
Intracellular 
 
40 
25 
15 
 
0 
 
60 
 
100 
40 
60 
 
0 
 
0 
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80% of occludin is present within the TJ while 20% is present at the lateral membrane. 
Interestingly, both these fractions are mobile. The confocal imaging of cells expressing 
EGFP-occludin shows occludin localized at TJ and also along the lateral membrane just 
below the TJ. The diffusion constant of occludin associated with TJ pool was found to be 
0.011 µm2s-1 while that of the occludin associated with the lateral membrane was found to 
be 0.1 µm2s-1. These data suggest that the diffusion of lateral membrane occludin is faster 
than that present at the TJ. Thus occludin exchange occurs by diffusion within and 
between TJ and lateral membrane. 
 
 
ZO-1 Exchanges with an Intracellular Pool 
 
Similar studies performed in cells expressing EGFP-ZO-1 showed that ZO-1 is 
highly mobile within the TJ. Cholesterol depletion by MBCD had no effect on ZO-1 
mobility but depletion of cellular ATP and continuous photobleaching of cytoplasm 
reduced fluorescence recovery of ZO-1. These data together indicate that a large fraction 
of TJ associated ZO-1 exchanges with an intracellular pool in an energy dependent 
mechanism.   
 
 
Claudin-1 Exchange Occurs by Diffusion within the Membrane 
 
Claudin-1 on the other hand is less mobile as the fluorescence recovery is low 
after photobleaching. Continuous photobleaching of TJ resulted in rapid loss of claudin-1 
fluorescence from junctions while that of cytoplasm had no effect. These data indicate 
that a small fraction of claudin-1 exchange occurs by diffusion within the TJ.  
 
These observations strongly suggest that the TJ components are highly dynamic, 
and that such dynamic properties have the potential to regulate paracellular permeability 
via the fine-tuning of signaling cascades involved in barrier function (5). Understanding 
TJ dynamics will unravel TJ components as targets for the development of therapeutic 
agents aimed at modulating barrier function. 
 
 
TJ Regulation by Occludin Phosphorylation 
 
TJ regulation occurs in health as well as disease. Besides forming a seal that 
maintains the compartmentation, TJ serve to regulate the paracellular transport under 
various physiological and pathophysiological conditions. Several stimuli and signaling 
molecules have been reported to regulate the later function of TJ. Occludin is known to 
be an important target that mediates TJ regulation in these signaling cascades. TJ 
modulation by occludin phosphorylation and dephosphorylation has been studied 
extensively. The kinases and phosphatases involved are listed in (Table 1-2) Mutational 
analyses pointed towards ORM and its role in TJ modulation (Table 1-3). 
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Table 1-2. Kinases and Phosphatases Associated with Occludin Phosphorylation. 
 
Phosphatase
/Kinase 
Experimental Model 
 
Phosphosite 
 
Reference 
 
CK1 
 
 
CK2 
 
 
 
c-Src 
 
 
c-Yes 
 
PKCη 
 
PP2A 
 
 
PP1 
 
DEP-1 
 
PI3K 
HUVEC  
GST-Ocl-C (Human) 
 
Xenopus laevis embryo 
GST-Ocl-C (Human) 
Caco-2 
 
Rat-1, MDCK 
Caco-2 
 
MDCK 
 
Caco-2, MDCK 
 
GST-Ocl-C (Human), Caco-2 
MDCK 
 
Caco-2, GST-Ocl-C (Chicken) 
 
MDCK  
 
Caco-2, GST-Ocl-C (Chicken) 
Thr, Ser 
Thr, Ser 
 
Thr 375, Ser 379  
Thr-400/404, Ser 408 
Ser 408 
 
Tyr-398, Tyr-402 
Tyr 
 
Tyr 
 
Thr-403, Thr-404 
 
Ser, Thr 
Thr 
 
Ser 
 
Tyr 
 
Tyr 
(46) 
(23) 
 
(47) 
(38) 
(37) 
 
(34) 
(33) 
 
(48) 
 
(35) 
 
(49) 
(50) 
 
(49) 
 
(51) 
 
(52) 
 
Source: Reprinted with permission. Cummins, P. M. (2012). "Occludin: one protein, 
many forms." Mol Cell Biol 32(2): 242-250. Copyright © 2012, American Society for 
Microbiology. 
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Table 1-3. Mutation Analyses of Phosphorylation Hotspot in Occludin. 
 
Kinase Mutation Effect on TJ Model Reference 
c-Src 
 
 
 
 
 
Y398/402D 
 
 
 
 
Y398/402A 
TJ-assembly ↓ 
Inulin permeability ↑ 
Junctional occludin ↓ 
Interaction with ZO-1↓ 
 
Junctional occludin↑ 
TJ-assembly→ 
Inulin permeability→ 
Caco-2 
MDCK 
Rat-1 
 
 
 
(33,34,53) 
PKCη T403/404D 
 
 
 
T403/404A 
 
 
 
TER ↑ 
Inulin permeability ↓ 
Junctional occludin↑ 
 
TER↓ 
Junctional occludin↓ 
Junctional ZO-1↓ 
Caco-2 
MDCK 
 
 
 
(35,54) 
 
 
 
  CK2 S408A 
 
 
 
S408D 
 
 
 
T404A/S408A 
 
 
 
T400A/T404A/ 
S408A 
Junctional occludin↑ 
Interaction with ZO-1 ↑ 
Occludin exchange ↓ 
 
Junctional occludin ↓ 
Interaction with ZO-1 ↓ 
Occludin exchange → 
 
Occludin exchange ↓ 
Interaction with ZO-1 ↑ 
TER↑ 
 
Interaction with ZO-2↓ 
TJ-assembly ↓  
Caco-2 
MDCK 
T84 
 
 
 
(37,38,47) 
 
Source: Modified with permission. Dorfel, M. J. and O. Huber (2012). "Modulation of 
tight junction structure and function by kinases and phosphatases targeting occludin." J 
Biomed Biotechnol 2012: 807356. Copyright © 2012 Max Johannes Dörfel and Otmar 
Huber. 
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Kinases 
 
 
 c-Yes. Tyrosine kinase, c-Yes was pulled down with the peptide that mimics 
coiled-coil domain of occludin indicating a direct interaction between c-Yes and occludin 
(55). C-Yes induced-dephosphorylation of tyrosine residues during Ca2+ depletion 
mediated TJ disassembly in MDCK-II cells, was attenuated by c-Yes inhibitor 
CGP77675. Hence c-Yes was believed to be a barrier promoting kinase (48). However, 
the phosphosites in occludin for c-Yes were not identified.  
 
 
 c-Src. Oxidative stress induced tyrosine phosphorylation of occludin and 
redistribution of occludin and ZO-1 (56). Expression of a kinase inactive c-Src delayed 
oxidative stress induced TJ disruption indicating that c-Src was the potential tyrosine 
kinase involved. c-Src was found to interact with GST tagged occludin c-terminus in 
vitro which decreased interaction between occludin and ZO-1 (33). Y398 and Y402 
present in a highly conserved motif YETDYTT were identified as the phosphosites for c-
Src (34). A phosphomimetic mutation of Y398/402D in occludin attenuated its 
interaction with ZO-1, delayed TJ reassembly during Ca2+ switch in MDCK cells and 
sensitized them to hydrogen peroxide induced barrier dysfunction (34). 
 
 
 FAK. Focal adhesion kinase plays a key role in the regulation of cytoskeleton, 
cell migration and adhesion. Acetaldehyde treatment in human colonic biopsies resulted 
in the activation of FAK, increased tyrosine phosphorylation of occludin and ZO-1 and 
redistribution of occludin from intercellular junctions. EGF or glutamine pretreatment 
was able to prevent these effects. 
 
 
PKCη . Over expression of constitutively active PKCη in Caco-2 and MDCK 
cells enhanced barrier function by increasing TER, decreasing inulin-flux and increased 
occludin localization at the intercellular junctions. These effects were blocked by the use 
of PKCη pseudosubstrate and shRNA-induced knockdown of PKCη. PKCη was shown 
to interact with occludin. By mass spectrometry and mutational analyses, T403 and T404 
were identified as the phsophosites for PKCη. T403A mutation partially blocked 
phosphorylation whereas T404A completely prevented it. T403/404D mutation enhanced 
occludin and ZO-1 localization at the intercellular junctions while T403/404A mutation 
decreased ZO-1 localization at junctions and occludin was seen mostly in the intracellular 
compartment (35). 
 
 
 PKCζ . Atypical PKC like was shown to interact with occludin C-terminus and 
phosphorylate T403, T404, T424 and T438. Inhibition of PKCζ using pseudosubstrate 
led in MDCK and Caco-2 cell led to decrease in TER, increase in permeability, decreased 
occludin phosphorylation, redistribution of occludin from the junctions and delayed Ca2+ 
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induced TJ reassembly. Mutation of T424/438 to alanine resulted in occludin localization 
in intracellular compartment and delayed Ca2+ induced TJ reassembly (57). 
 
 
CK2. Casein kinase 2 is a tetrameric serine/threonine kinase with two catalytic 
subunits(a,a’) and two regulatory b-subunits. In vitro phosphorylation studies revealed 
that CK2 interacts with occludin and phosphorylates T400, T404 and S408. A triple 
mutant T400A/T404A/S408A blocked complete phosphorylation of occludin in vitro. In 
Caco-2 cells, knockdown of CK2 or pretreatment with CK2 inhibitors enhanced barrier 
function by increasing TER and decreasing paracellular flux of sodium ions. FRAP 
studies using occludin knockdown-Caco-2 cells expressing EGFP-occludin showed that 
CK2 inhibition reduced mobile fraction of occludin. Mutants S408A and T404A/S408A 
showed decreased mobility compared to wild type occludin, S408D and T404D/S408D 
mutants (38). It was postulated that S408 phosphorylation might act as a switch that 
regulates TJ permeability by determining whether occludin forms homodimers or 
heteromeric interactions with ZO-1, claudin-1 and claudin-2 (37).  
 
 
PI3K. Phosphatidyl inositol-3 kinase, regulatory subunit p85 was found to 
directly interact with coiled-coil domain of occludin c-terminus (55). Oxidative stress 
induces translocation of p85 to the junctions and increased association with occludin. 
Treatment of T84 cell monolayers with LY294002, a PI3K inhibitor, attenuated tyrosine 
phosphorylation of occludin, decrease in TER, increase in permeability and redistribution 
of occludin and ZO-1 from the junctions (52). Hence it was believed that PI3K activity is 
involved in dissociation of TJ during oxidative stress.  
 
 
Phosphatases 
 
 
 PP2A and PP1. Protein phosphatase 2A and 1 (PP2A and PP1) are 
serine/threonine phosphatases ubiquitously expressed and associated with multiple 
functions. In MDCK cells, enhanced PP2A activity induced dephosphorylation of 
occludin and increased paracellular permeability which was attenuated by pretreatment 
with okadaic acid, a PP2A inhibitor (50). In Caco-2 cells, inhibition of PP2A activity by 
okadaic acid and fostriecin, resulted in enhanced TJ reassembly after Ca2+ switch. 
SiRNA-mediated reduction of PP2A activity enhanced Ca2+ induced increase in TER, 
decrease in inulin permeability and enhanced junctional localization of occludin and ZO-
1 during TJ reassembly. By in vitro assays it was found that PP2A dephosphorylates 
phospho-occludin on threonine residues while PP1 dephosphorylates on serine residues. 
Both PP2A and PP1 were found to interact with occludin C-terminus and negatively 
regulate TJ assembly (49).  
 
 PP2A was also shown to be involved in hydrogen peroxide induced TJ disruption 
in Caco-2 cell monolayers. Hydrogen peroxide enhanced association between occludin 
and PP2A in Caco-2 cells, which was blocked by a SC kinase inhibitor, PP1 suggesting 
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that this interaction is a tyrosine kinase dependent mechanism (58). Acetaldyde induced 
TJ disruption also involves dephosphorylation of occludin by PP2A in Caco2 cell 
monolayers. Acetaldehyde treatment increased translocation of PP2A to TJ and induced 
threonine dephosphorylation of occludin (59). 
 
 
 DEP1. (Density-enhanced protein tyrosine phosphatase-1) has been shown to 
interact with occludin in MDCK-II cells. Overexpression of DEP-1 in these cells led to 
increased TJ reassembly and enhanced barrier function. Knockdown of DEP-1 resulted in 
increased permeability (51). 
 
 
Cytokine-induced TJ Regulation Involves Occludin 
 
 Modulation of TJ without altering TJ protein expression has been shown to occur 
during physiological regulation of TJ by SGLT-1 (Sodium glucose transporter-1) and 
pathophysiological regulation of TJ by proinflammatory cytokines like TNF and IL1-β. 
Myosin light chain kinase (MCLK) is the key player underlying these processes. Na+-
glucose cotransport activation leads to MLCK mediated phosphorylation of MLC. This 
leads to perijunctional actomyosin contraction and increased paracellular permeability. 
TNF also induces activation of MLCK, which in turn induces actomyosin condensation 
by MLC phosphorylation and increases paracellular permeability. Exposure to T-cell 
derived cytokines in intestinal epithelial cells leads to caveolin mediated endocytosis of 
occludin as a result of MLCK activation. This effect was blocked by inhibition of MLCK 
as well as by drugs that block caveolar pathway.  
 
In mice expressing EGFP-tagged occludin, exposure of the intestinal epithelium 
to TNF induced focal accumulation of occludin, which was blocked by inhibitors of 
caveolar pathway. These data suggested that TNF induced TJ regulation involves 
endocytosis of occludin. In HT-29/B9 cells, TNF and interferon-gamma exposure 
diminished occludin promoter activity, which resulted in enhanced paracellular 
permeability associated with occludin downregulation (60). 
 
 
VEGF 
 
 Vascular endothelial growth factor (VEGF) is known to be an important mediator 
of vascular permeability and TJ deregulation in blood-brain and blood-retinal barriers. 
VEGF was found to induce phosphorylation of S490 of occludin (61). This enhances 
interaction with E3 ubiquitin ligase and induces occludin ubiquitination. VEGF induced 
occludin phosphorylation in BRECs resulted in increased permeability and decreased 
TER (30). Thus VEGF alters TJ and increases vascular permeability in brain and retinal 
disorders. Human intestinal adenocarcinoma was shown to exhibit decreased occludin 
expression and tumor derived VEGF is known to play an important role in occludin 
degradation and tumor metastasis (28). 
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Occludin Variants 
 
Occludin is known to exhibit functional diversity by means of its variants 
generated by gene splicing and alternate promoter usage. Saitou et al (62) were the first 
to report isoforms of occludin, generated by alternative splicing. 
 
 
Occludin with N-terminus Extension 
 
Occludin 1B, originally identified in MDCK cells is an alternatively spliced 
variant with a 193-bp insertion that encodes an occludin isoform with a 56 amino acid N-
terminal extension (63). This was later found to be expressed in human colon carcinoma 
cells and mouse intestine. It was known to localize at the junctions similar to wild type 
occludin. The extended N-terminus of occludin 1B was believed to mask the SH3 motif 
and hinder binding interactions with SH3 adaptor proteins. 
 
 
Occludin with TM4 Deletion 
 
TM4 (-), identified in human tissues, embryos, epithelial and endothelial cells, is 
an isoform generated by skipping exon 4 leading to a 162-bp deletion that encodes TM4 
and proximal c-terminus region. TM4 (-) also referred to as type II occludin, failed to 
localize at the junctions because of the externalized C-terminus, and does not colocalize 
with ZO-1. It was believed that low-level expression of TM4 (-) occurs during tissue 
remodeling,   
 
 
Occludin with Alternate Promoter (Exon 1a) 
 
This variant was known to be generated using second occludin promoter and 
transcription start site (exon 1a). It has enhanced sensitivity TNF signaling and believed 
to have a pathological role inducing colonic inflammation in ulcerative colitis.  
 
 
Occludin with Alternate Promoter and Exon 9 Deletion 
 
OccΔE9 was identified in human liver cells. This isoform localized in the 
cytoplasm and failed to induce apoptosis like the canonical occludin and hence was 
speculated to have a role in metastasis. 
 
 
Significance 
 
Although the studies so far did not confirm the functional significance of these 
occludin variants, it is strongly believed that they are expressed under conditions of 
physiological regulation of TJ or during disease pathogenesis and cancer progression. 
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Occludin in Disease Pathogenesis 
 
Occludin is an important target during barrier breach and hence is associated with 
several disease processes. In all these cases occludin is subjected to either 
downregulation or altered subcellular localization.  
 
 
Diarrhea 
 
Pathogenic toxins that target gastro intestinal tract mediate disease pathogenesis 
by mechanisms that involve occludin and increase in paracellular permeability. Listed 
below are some of the examples. 
 
a. Gliadin exposure to intestinal biopsies from celiac patients increased permeability 
to macromolecules by Zonulin release and loss of occludin-ZO1 interaction (64).  
 
b. Enteropathogenic Escherichia coli (EPEC) secretes a protein called EspF that 
increases intestinal permeability, reduces TER and dissociates occludin from TJ 
by inducing dephosphorylation (65).  
 
c. Clostridium perfringens enterotoxin  (CPE) forms a large protein complex with 
occludin that increases permeability and induces cytotoxicity in Caco-2 cells (66). 
 
d. Vibrio cholera produces a cytotoxin, hemagglutinin/protease (HA/P) that causes 
barrier dysfunction by degrading occludin and perturbing actin cytoskeleton in 
MDCK-I cells. This leads to decrease in TER and loss of TJ strands (67).  
 
e. Clostridium difficile toxins A and B are UDP-glucosyltransferases that 
glucosylate and inactivate Rho. This induces cytoskeletal disorganization, 
dissociation of occludin and ZO-1 from TJ and increases TJ permeability in T84 
intestinal epithelial cells (68). 
 
 
Inflammation 
 
TJ barrier dysfunction associated increase in epithelial permeability is believed to 
either predispose or enhance disease progression. Crohn’s disease and ulcerative colitis 
are collectively referred to as inflammatory bowel disease (IBD). Patients with IBD 
exhibit increased intestinal paracellular permeability and decreased occludin expression. 
IBD pathogenesis involves production of a cytokine like tumor necrosis factor (TNF). 
MLCK expression and activity were also enhanced in intestinal epithelium of IBD 
patients. Thus TNF induced occludin downregulation and occludin endocytosis by 
MLCK activation are the key mechanisms underlying barrier dysfunction mediated 
disease progression. 
 
 
 21 
Cancer 
 
TJ between cells confer cell-cell adhesion and maintain integrity of the 
epithelium. Hence it is believed that the TJ disassembly is required for the cells of 
neoplastic epithelium to metastasize. The process of metastasis involves TJ disruption-
mediated detachment of tumor cell from its primary site, intravasation through the 
endothelial barrier often induced by secretion of growth factors like VEGF, HGF and 
extravasation of the circulating tumor cell leading to invasion of other tissues. The 
following are the instances where occludin down regulation induced TJ dysfunction aids 
in metastases of various tumors. 
 
a. Tumors of rat and human colon showed increased permeability while histological 
analysis of human intestinal adenocarcinomas showed reduced expression of 
occludin.  A correlation between tumor differentiation and occludin expression 
was reported (69).  
 
b. Hepatocyte growth factor or scatter factor (HGF/SF), a cytokine released by 
stromal cells is known to increase paracellular permeability, decrease TER and 
alter occludin expression in human breast cancer cell lines. Down regulation of 
occludin is believed to play a role in metastasis of breast cancer cells (70).  
 
c. In human endometrial cancer, with the increase in carcinoma grade, expression of 
occludin was found to be decreased. Decreased occludin expression was also 
found during invasion of the myometrium and lymph node metastasis (71). 
 
 
Alcoholic Endotoxemia  
 
 Alcohol increases paracellular permeability to endotoxins in the gut. Alcohol 
induced endotoxemia is involved in the pathogenesis of alcoholic liver disease (ALD) 
(72). Ethanol and its metabolite acetaldehyde induced TJ and AJ disruption in Caco-2 cell 
monolayers. Acetaldehyde treatment in these cells induced occludin redistribution from 
intercellular junctions. This involved dephosphorylation of occludin on threonine 
residues mediated by PP2A (59). In a recent study using occludin knock out mice, we 
showed that lack of occludin exacerbates chronic ethanol-induced increase in colonic 
mucosal permeability. Similarly, using shRNA mediated occludin knock down, 
acetaldehyde exposure in Caco-2 cell monolayers was shown to enhance TJ disruption 
and barrier dysfunction (73). These data suggest that occludin plays an important role in 
barrier function and that its disruption sensitizes TJ to alcohol induced endotoxemia. 
 
 
Hepatitis 
 
Human occludin was identified as an important entry factor for hepatitis C virus 
(HCV) infection. Occludin silencing impaired infection of lentiviral particles bearing 
HCV glycoprotein (HCVpp) (74). A later study showed that occludin interacts with HCV 
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glycoprotein (HCVgp). Occludin knock down led to reduced infection by cell culture 
derived HCV particles.  Thus occludin plays an essential role in HCVgp fusion at late 
entry events of HCV infection (75). A recent study showed that HCV infection in 
hepatoma cells induced an increase in occludin expression and upregulation of adipose-
differentiation related protein. (ADRP). In HCV-infected human livers, ADRP mRNA 
expression levels correlated with that of occludin  
 
 
Miscellaneous 
 
a. Oncogenic Raf1 mediated tumorigenesis causes downregulation of occludin in rat 
salivary gland epithelial cells. The second extracellular loop of occludin is known 
to be required for inhibition of Raf-1 mediated tumorigenesis in vitro and in vivo 
(76,77).  
 
b. Ras-transformed MDCK cells have loss of occludin and ZO-1 from TJ. This 
increased TJ permeability is known to involve MAPK signaling pathway. Ras 
mutations are known to cause barrier dysfunction by altering occludin and 
claudin-1 levels at TJ (78). 
 
c. Rho Kinase (RhoK) activation mediated occludin phosphorylation is associated 
with barrier leakiness in the case of human immunodeficiency virus encephalitis 
(HIVE) (79). Malignant brain tumors also displayed leaky endothelial TJ and loss 
of occludin expression (80).  
 
d. Helicobacter pylori sonicates are known to increase gastric permeability by 
altering expression of occludin in a PKC dependent mechanism (28). 
 
e. A discontinuous staining pattern of occludin in blood brain endothelium is 
considered a hallmark of HIVE (HIV associated encephalitis) (79).  
 
f. Serum from multiple sclerosis patients induced downregulation of occludin in 
cultured endothelial cells (81). 
 
 
Hypothesis and Specific Aims 
 
Epithelial TJ serve as a critical intercellular barrier against paracellular 
permeation of luminal antigens, toxins and pathogens. TJ disruption-induced increase in 
paracellular permeability leads to edema, jaundice, enterocolitis, alcoholic endotoxemia, 
IBD, celiac disease and colon cancer. Hence understanding the dynamic nature of TJ 
barrier is crucial to determine their physiological role in normal development and during 
pathogenesis.  
 
TJ is known to be a highly dynamic multi-protein complex with its components 
occludin, claudins and ZO-1, each exhibiting a unique dynamic behavior. Yet, the 
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contributing factors for this dynamic nature remain elusive. It is well accepted that 
occludin phosphorylation in a highly conserved region (Tyr398-Ser408), which we call 
ORM, plays a role in TJ regulation. However, the function of this motif in TJ dynamics is 
not well defined.  
 
 
Hypothesis 
 
Based on the above observations, we hypothesized that ORM confers dynamics to 
epithelial TJ and regulates barrier function by ORM-mediated protein-protein 
interactions. Our goal is to investigate the functional significance of ORM and ORM-
mediated signaling mechanisms that underlie TJ regulation. This goal will be achieved by 
conducting studies under the following specific aims. 
 
 
Specific Aim 1: To Determine That ORM Confers Dynamics to TJ in a 
Phosphorylation-dependent Mechanism 
 
Studies designed here were aimed to determine the function of ORM in TJ 
dynamic using a deletion mutant of occludin that lacks ORM. Furthermore, double point-
mutants of occludin phosphosites were used to establish the significance of ORM 
mediated phosphorylation in TJ dynamics. 
 
 
Specific Aim 2: To Determine That ORM-mediated Protein Interactions Are 
Involved in TJ Modulation  
 
Studies designed here were aimed to identify the proteins that interact with ORM, 
using a synthetic peptide that mimicked ORM. Furthermore, the functional significance 
of ORM-mediated protein interactions was established in relation to TJ modulation. 
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CHAPTER 2.    MATERIALS AND METHODS  
 
 
Cell Culture and Transfection 
 
 
Cell Lines 
 
 Madin-Darby canine kidney (MDCK) cell line was originally derived from kidney 
tissue of a normal adult female dog. These cells are known to exhibit apico-basolateral 
polarity and well-defined cell junctions.  Hence they have been widely used to study tight 
junctions, protein trafficking and polarity associated with epithelial cells. MDCK cells 
were purchased from American Type Cell Culture (ATCC). They were grown in 
Dulbecco’s modification of eagle’s medium (DMEM) supplemented with 10% (v/v) fetal 
bovine serum (FBS), 1mg/10ml primocin and maintained at 370C and 5% carbon dioxide 
(CO2).  
 
 Caco-2 cells were isolated from adenocarcinoma of a 72-year old Caucasian male. 
These cells after differentiation are known to express brush border enzymes and 
microvilli on their apical membrane. Caco-2 cells are widely used to study intestinal 
permeability and cell signaling, as they closely resemble the intestinal epithelium when 
grown on polycarbonate transwell inserts. Hence this cell line is treated as an ideal model 
to study intestinal barrier function. Caco-2 cells were purchased from American Type 
Cell Culture (ATCC). They were grown in Dulbecco’s modification of eagle’s medium 
(DMEM) supplemented with 20% (v/v) fetal bovine serum (FBS), 1mg/10ml primocin 
and maintained at 370C and 5% carbon dioxide (CO2).  
 
 
Occludin Gene Silencing 
 
 For occludin gene silencing in canine MDCK cells, vector-based short hairpin 
RNA (shRNA) was designed using the Dharmacon Web site (siDesign® Center, 
http://www.dharmacon.com/DesignCenter/) and cloned into pRNAtin-U6 vector 
(GenScript). Two targeting sequences were chosen against the nucleotide sequence of 
canine occludin gene using the Dharmacon web site (Target1: 
TATGTCAGACCTTATAACG; Target2: TATGCTACCACCCATTAAG). The 
sequences were further verified by BLAST search on the known human genome 
database, and no matches were found confirming the uniqueness of these sequences.  
 
To construct the shRNA vectors, two pairs of oligonucleotides containing the 
antisense sequence, a hairpin loop region (TTGATATCCG), and the sense sequence with 
cohesive BamHI and XhoI sites were synthesized (Sigma Genosys, St Louis, MO) using 
the primers provided in the table (Table 2-1). The top and bottom strands were annealed 
and cloned into BamHI and XhoI sites of the pRNAtin-U6 vector (GenScript Corp., 
Piscataway, NJ) (pR vector), which induces expression of shRNA by U6 promoter. 
Successful insertion of the shRNA constructs into the vector was confirmed by releasing  
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Table 2-1. Primers for Knockdown and Mutation of Occludin. 
 
Primer Sequence 
cOCN-shRNA1-Top strand GATCCCGTATGTCAGACCTTATAACGTTGA
TATCCGCGTTATAAGGTCTGACATATTTTTT
CCAAA 
cOCN-shRNA1-bottom strand AGCTTTTGGAAAAAATATGTCAGACCTTAT
AACGCGGATATCAACGTTATAAGGTCTGAC
ATACGG 
cOCN-shRNA2-Top strand GATCCCGTATGCTACCACCCATTAAGTTGA
TATCCGCTTAATGGGTGGTAGCATATTTTT
TCCAAA 
cOCN-shRNA2-bottom strand AGCTTTTGGAAAAAATATGCTACCACCCAT
TAAGCGGATATCAACTTAATGGGTGGTAGC
ATACGG 
Δ388-415 Forward TGGATCAGGGAATATCCACCTATCA 
Δ388-415 Reverse TGCTCTTCCCTTTGCAGGTGCTCT 
Y398/402A 
 
CAGAGCAAGATCACGCTGAGACAGACGC
CACAACTGGCGGCGAG 
Y398/402D 
 
CAGAGCAAGATCACGATGAGACAGACGA
CACAACTGGCGGCGAG 
T403/404A CAAGATCACTATGAGACAGACTACGCAGC 
T403/404D CTATGATCACTATGAGACAGACTACGATG
ATGGC 
T400/403/404A GATCACTATGAGGCAGACTACGCAGCTGG
CGGCG 
T400/403/404D 
 
CTATGATCACTATGAGGATGACTACGATGA
TGGCGGCGAGTCC 
 
Note: pEGFP occludin wild type construct was used as the template for all mutations 
except T403/404A and T403/404D, where templates were T400/403/404A and 
T400/403/404D respectively.  
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the oligonucleotides by digesting with BamHI and XhoI and sequencing. For a control, a 
mutant form of shRNA was designed by replacing adenine and guanine nucleotides with 
cytosine and adenine, respectively. 
 
 
ORM Deletion Mutation 
 
ORM deletion mutant was generated in a pEGFP-human occludin construct by 
inverse PCR using primers flanking the ORM region. The PCR product was treated with 
DPn1 to digest the plasmid DNA and a self-ligation was performed by a reaction with T4 
polynucleotide kinase and T4 DNA ligase (New England Biolabs Inc., Beverly, MA). 
The mutation was confirmed by restriction digestion, PCR amplification and sequencing. 
The mutant construct was transformed into XL10 gold competent cells for DNA 
amplification. This resulted in a deletion mutant of occludin (OclDM: Δ388-415) lacking 28 
amino acids (GRSKRTEQDHYETDYTTGGESCDELEED) in its C-terminus.  
 
 
Transfection 
 
 Stable clone of occludin knock down MDCK cell line (OD-MDCK) generated by 
shRNA transfection were grown in Dulbecco's modified Eagle's medium supplemented 
with 10% fetal bovine serum  (Gibco), primocin (100ug/ml; Invivogen) and hygromycin 
(100ug/ml; Thermo Fischer).  The constructs pEGFP-occludinWT, pEGFP-occludinDM or 
vector alone were transfected into OD-MDCK cells using lipofectamine 2000 
(Invitrogen). Stable clones of OD-MDCKWT, OD-MDCKDM and OD-MDCK-Vec were 
generated by G418 mediated selection and dilution cloning. At least 12 clones from each 
group were screened for GFP fluorescence by live-cell confocal imaging and protein 
expression by western blot analysis. 
 
 
Fluorescence Microscopy 
 
 
Immunofluorescent Staining 
 
Cell monolayers or tissue cryosections were fixed in either acetone/ methanol 
(1:1) at 0 °C for 5 min or 3% paraformaldehyde (for staining actin-cytoskeleton) at room 
temperature for 15 min. Those fixed in acetone/methanol were stored at -20 °C while 
those fixed in paraformaldehyde were stored in PBS at 4 °C for not more than a week. On 
the day of staining, fixed monolayers or cryosections were washed twice with PBS and 
permeabilized in 0.2% Triton X-100 for 10min. After washing three times with PBS, they 
were blocked using 4% milk in TBST (20mM Tris, 150mM NaCl, pH 7.2) for 30 min at 
room temperature. Then they were incubated with primary antibodies in 4% milk (anti-
ZO-1, anti-GFP, anti-occludin, anti-MAP7, anti- β-tubulin, anti-E-Cadherin, anti-β-
catenin) for 1 hour at room temperature. The monolayers were washed with 1% milk 
followed by incubation with secondary antibodies (Alexa Fluor 488-conjugated anti- 
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mouse and Cy3-conjugated anti-rabbit IgG) in 4% milk. Nuclear staining was done using 
Hoechst 33342. F-actin and biotin were stained with AlexaFluor-488 conjugated 
phalloidin and Cy3 conjugated streptavidin respectively. The monolayers were mounted 
on a slide using mounting fluid and sealed for imaging. 
 
 
Microscopy 
 
• Fluorescence was visualized in a Zeiss LSM 5 laser scanning confocal 
microscope. The images from Z-series sections (1µm thickness) were collected by 
Zen software. The z-series images were stacked by using the software, Image J 
(National Institutes of Health), and processed by Adobe Photoshop (Adobe 
Systems). 
 
• For time-course imaging studies, confluent cell monolayers grown in 60mm 
culture plates were imaged using a 20X objective of the confocal microscope. 
Cells were maintained in an incubator at 37 °C during the course of the 
experiment. For cells in chamber slides, imaging was done by Nikon 
epifluorescence microscope using a 40X objective.  
 
 
Analysis of Barrier Function and TJ Integrity 
 
 
Barrier Function Parameters 
 
Cells were grown in transwell inserts (12mm; Costar) to achieve confluence at a 
density of 3x 105 cells per well. The experiments were performed on days 1-4 in MDCK 
cells and on days 7-10 in Caco-2 cells. Barrier function of the monolayers was monitored 
by measuring electrical resistance of the barrier and unidirectional flux of FITC-inulin.  
 
• Trans-epithelial Electrical Resistance (TER) is a measure of the flux of all ions 
across the epithelium. TER was measured by using a Millicell-ERS Electrical 
Resistance System (Millipore, Bedford, MA). Basal TER of semi-permeable 
membrane of transwells was subtracted from all values (80-100 Ohms/cm2).  
 
• Unidirectional FITC-inulin flux. FITC-inulin (6 kDa; 0.5 mg/ml) was 
administered to the buffer in the apical well. At the end of incubation, 100 µl of 
basal medium and 20 µl of apical medium were sampled, and fluorescence was 
measured using an Flx-800 microplate fluorescence reader (BioTEK instruments, 
Winooski, VT). Flux into the basal well was calculated as the percentage of total 
apical well fluorescence/cm2 surface area.  
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TJ Integrity 
 
 Cell monolayers were fixed in acetone/ methanol (1:1) for staining occludin, GFP, 
ZO-1, E-cad, b-catenin and cld-2 while cells were fixed in 3% paraformaldehyde for 
staining actin and tubulin. TJ integrity of the monolayers was analyzed by confocal 
microscopy. 
 
 
FRAP  
 
FRAP (Fluorescence recovery after photo-bleaching) studies were performed 
using a module available in the Zen software. The principle involved in FRAP is 
represented in the schematic (Figure 2-1). Cells stably expressing GFP-tagged occludin 
and its mutants were grown to confluence in 60mm culture plates. During imaging, cell 
monolayers were washed and placed with DMEM without glutamine and phenol red. 3-4 
regions of interest (ROI), provided in the module were defined at the intercellular 
junctions of the monolayer. High intensity laser was used at 488nm to bleach the ROI, 
with a specific number of iterations. The module was set to capture at least 3 images 
before the bleach and time-lapse images up to ~25 min after the bleach.  
 
All the images were collected at the same focal plane. The time series images 
were processed by using ImageJ software and confirmed by manual calculation. 
Fluorescent intensity was measured at varying times after bleaching to calculate percent 
recovery. Percent recovered at 25 min was considered as percent mobile fraction.  
 
 
Protein Analyses 
 
 
Preparation of Triton-soluble and Triton-insoluble Fractions 
 
 Cell monolayers in 60mm culture plates were incubated with 500 µl lysis buffer-
CS (Tris buffer containing protease inhibitor cocktail (10ul/ml), 1 mM vanadate, and 1 
mM PMSF) on ice for 15min. Cell lysates were centrifuged at 15,600 g for 4 min at 4°C 
to sediment the high-density actin cytoskeleton. The supernatant was used as the triton-
soluble fraction.  
 
The pellet that is known to contain membrane associated TJ components, was 
suspended in 200 µl of lysis buffer-CS and sonicated to homogenize the actin 
cytoskeleton. This was used as triton-insoluble fraction. Protein contents in both fractions 
were measured by the BCA method (Pierce Biotechnology, Rockford, IL). The protein 
fractions were mixed with equal volume of 2X Laemmli's sample buffer and heated at 
100°C for 10 min. 
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Figure 2-1. Fluorescence Recovery after Photobleaching (FRAP). 
 
A. Live-cell images of a confluent monolayer are captured before photobleaching. A high 
intensity laser is used to bleach a specified region of interest (ROI) at intercellular 
junctions. Time-lapse images post bleaching are captured until the fluorescence intensity 
reaches a plateau. B. A plot of fluorescence intensity (I) versus time (t) gives a measure 
of mobile (Fm) and immobile fractions (FI and half time of recovery (thalf). 
  
 30 
Immunoprecipitation 
 
 Confluent monolayers (60mm culture plates) were washed with ice-cold PBS and 
proteins were extracted in 500ul ice-cold lysis buffer (10mM Tris/Cl pH 7.5 containing 
150mM NaCl, 0.5mM EDTA, 0.5% NP40, 1mM PMSF, 1x Protease inhibitor cocktail). 
The lysates were centrifuged at 15600g for 4 min at 4 °C. The supernatant was separated 
and the pellet was resuspended in 200ul lysis buffer and sonicated for 10 sec to induce 
fragmentation of F-actin filaments and release actin-bound TJ proteins. Previous studies 
showed that nearly 80% of the occludin and ZO-1 was recovered in this fraction. This 
was centrifuged at 13500rpm for 10 min and the supernatant was pooled with the 
previous. The protein concentration was quantitated by BCA method. The total lysates 
(1.0 mg protein/ml) were incubated with prewashed 25 ul GFP-Trap_A beads 
(Chromotek, Germany) at 4 °C for 1 h. The immune complexes were isolated by 
centrifugation at 2000g for 2 min at 4 °C, followed by washes with Tris buffer and 
suspended in equal volume of Laemelli sample buffer (2 x concentrated). The protein was 
extracted by heating the samples at 100 °C for 10 min and centrifuging at 13500 rpm for 
10min. For immunoprecipitation of p-Thr, lysates were heated in the presence of 0.3% 
SDS for 10 min at 100 °C followed by centrifugation. The clear supernatant was then 
used for immunoprecipitation. 
 
 
Immunoblot Analysis  
 
 Protein samples were separated by 7% SDS-polyacrylamide gel electrophoresis 
and transferred to polyvinylidene diflouride (PVDF) membranes. Membranes were 
blotted for occludin, ZO-1, GFP, actin, claudin-2, Peroxiredoxin 1 and MAP7 using 
specific primary antibodies in combination with secondary HRP-conjugated anti-mouse 
IgG or HRP-conjugated anti-rabbit IgG antibodies. GST was immunoblotted using HRP-
conjugated anti-GST antibody. The blots were developed using ECL chemi-luminescence 
method (Amersham, Arlington Heights, IL). 
 
 
Ca2+ Switch Assay 
 
Cells expressing GFP-OclWT and its mutants were grown to confluence in 
transwells or 60 mm culture plates. The principle involved in Ca2+ switch assay is 
represented in the schematic (Figure 2-2). LCM was prepared from Ca2+ free DMEM 
(Thermo Fisher Scientific, Tustin, CA.) supplemented with 1 mM Sodium pyruvate, 2 
mM glutamine, 5% dialyzed fetal bovine serum and 10 µM calcium chloride. Barrier 
function was monitored by incubating cells in LCM for 16-24 hr. TER and inulin-flux 
were measured in transwells at time points ranging from 1 to 24 hr. The media was then 
switched with complete media containing NCM and barrier function was monitored for 2 
hr.  Live-cell imaging of GFP was performed in confluent monolayers in 60 mm dishes. 
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Figure 2-2. Ca2+ Switch Assay. 
 
Ca2+ switch technique is used to study de novo assembly and disassembly of TJ. 
Confluent cell monolayers are incubated in Ca2+ depleted media to induce TJ 
disassembly. Then the low calcium media (LCM) is switched with normal calcium media 
(NCM) to induce TJ assembly. TJ integrity is monitored by measuring TER, flux and 
imaging. 
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Recombinant GST-Ocl-C Expression 
 
 
Transformation 
 
 The C-terminal region of human occludin encoding the amino acid sequence from 
378-522 (Ocl-C) was amplified from the pEGFP-Occludin vector. The amplicon was then 
cloned into pGEX-2T vector (Amersham, Arlington Heights, IL).  Recombinant Ocl-C 
was produced as GST fusion protein (GST-Ocl-C) by transformation of the construct in 
E. coli BL21cells. Glycerol stocks were prepared and stored at -80°C. 
 
 
Culture Scale-up 
 
 The culture from glycerol stock was streaked on agar containing ampicillin (Amp; 
50ug/ml). The resistant colony was inoculated in 2ml LB-broth and incubated at 37°C 
and 250 rpm for 6-8hr. This 2ml culture was then transferred to 100ml LB+Amp and 
incubated at 37°C and 250 rpm overnight. The culture was then inoculated into 400ml 
LB+Amp and incubated at 37°C and 250 rpm. After 2 hr, 500ul or 0.5 ml of 1M IPTG 
(1mM) was added to the 500ml culture and incubated for another 4.5 hr. The culture was 
centrifuged at 3500rpm for 30min at 4°C. The supernatant was discarded and the pellet 
was stored at -80°C. 
 
 
Protein Extraction 
 
 The pellet was resuspended thoroughly in 15ml lysis buffer (50mM Tris, 1mM 
EDTA, 10% Sucrose, pH 7.3) containing protease inhibitor cocktail 10ul/ml each of  
PMSF, NaF, Na3VO4. 1.5ml lysozyme (10mg/ml) was added and incubated with rotation 
at 4°C for 30min. 0.75ml of freshly prepared 10% NP40 (IGEPAL) detergent was added 
and incubated further on the rotator for another 30 min at 4°C. The Lysate was sonicated 
to a uniform suspension setting 15 with 1-second strokes (30 strokes). The suspension 
was then centrifuged at 12000rpm (20,000g) for 1hr and supernatant was collected. 
 
 
Protein Purification 
 
 750ul of GSH agarose (Sigma) beads (per 15ml supernatant) was prewashed with 
cold PBS-IF three times by centrifuging at 13500rpm for 2 min at 4°C. The beads were 
added to the extracted supernatant and incubated for 2hr on the rotator at 4°C. After the 
incubation, the beads were collected by centrifuging at 13500rpm for 10min at 4°C. The 
beads were washed 5 times with cold PBS. Then 1ml of reduced glutathione (20mM) was 
added to the beads and incubated for 5min on the rotator. Supernatant was collected by 
centrifuging at 2000rpm for 1min at 4°C.  
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Dialysis 
 
 Supernatant was injected into dialysis cassette (3500 MWCO) and immersed with 
a floater in dialysis buffer (50mM Tris, 150mM NaCl, 0.5mM EGTA, 0.05% beta 
mercaptoethanol). Buffer was changed every 2 hours, 3 times and then left overnight. 
Protein was estimated in the dialyzed sample. 
 
 
Occludin Regulatory Peptide (ORP) 
 
 
ORP Characteristics 
 
 Occludin regulatory peptide (ORP) was custom synthesized by Biomatik. ORP 
comprises of amino acid sequence analogous to ORM (Mol.wt 458193) with a biotin tag 
at its N-terminus and a TAT sequence at its C-terminus. The molecular formula of ORP 
is C189H290N63O67S2. A stock solution of 1mM ORP in water was prepared for the 
experiments. Peptide with scrambled sequence was used as control referred to as ORPscr. 
 
 
ORP Permeability Studies 
 
• Caco-2 cell monolayers were grown to confluence on transwells. Cells were 
treated with 3µM and 10µM ORP and incubated at 37 °C for 30 min. The 
monolayers were fixed and probed with Cy3 conjugated Streptavidin. Fluorescent 
images were collected by confocal microscopy.  
 
• Intestinal sacs from C57BL/6 mice were prepared. One end of the intestinal 
segment was sutured and 10µM peptide solution containing FITC-inulin 
(0.5mg/ml) was injected from the other end. This end was then sutured to form a 
sac. The sacs were incubated in DMEM at 37 °C for 1hr. Cryosections were 
prepared and immunostained for ZO-1, biotin and nucleus. 
 
 
Ca2+ Switch Assay in Presence of ORP 
 
 Caco-2 cells were seeded on transwells and allowed to become confluent. Cells 
were exposed to DMEM containing 4mM EGTA for 20 min. Following EGTA treatment 
media was replaced with DMEM containing 10µM ORP and FITC-inulin (0.5mg/ml). 
TER and inulin flux were measured every hour up to 6 hours during recovery. Cell 
monolayers were fixed in acetone: methanol mixture and immunostained for occludin 
and ZO-1. 
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Irradiation in Presence of ORP 
  
 Confluent monolayers of Caco-2 cells in transwells were exposed to radiation 
(4Gy) and barrier function was compared to the sham treated control. Following radiation 
FITC-inulin was added to the media and flux and TER were measured every hour up to 5 
hr. Next, the cell monolayers were pre-incubated with 10µM ORP for 30 min and then 
exposed to radiation. Following radiation, FITC-inulin was added and barrier function 
was assessed by measuring TER and inulin flux. The cell monolayers were fixed and 
immunostained for occludin, ZO-1 and nucleus.  
 
 
ORP Pull Down Assay 
 
 
ORP Phosphorylation  
 
• ATP working solution was prepared in Mg buffer containing 20mM MOPS, 
25mM β-glycerophosphate, 750 mM MgCl2, 5 mM EDTA, 1 mM vanadate and 
1mM DTT. 
 
• To induce tyrosine phosphorylation, ORP (1mM) was incubated with 0.5ug active 
c-Src in tyrosine kinase buffer (50 mm Hepes, pH 7.4, 1 mm EDTA, 0.2% β-
mercaptoethanol, 3 mm MgCl2) containing 100 µm ATP at 30 °C for 3 hr on a 
thermo mixer. Control reactions were performed in the absence of ATP. 
 
• To induce threonine phosphorylation, ORP (1mM) was incubated with 0.5ug 
casein kinase-2 (CK-2) in threonine kinase buffer (80 mM MOPS/NaOH (pH 7.0) 
containing 2 mM EDTA) containing 100 µm ATP at 30 °C for 3 hr on a thermo 
mixer. Control reactions were performed in the absence of ATP. 
 
• ORP was trypsin digested to remove TAT sequence. Trypsin stock solution of 
200 µg/ml was prepared by dissolving 20 µg of lyophilized trypsin in 100 µl of 
resuspension buffer (50 mM acetic acid). Trypsin stock was diluted 1 in 5 in 
112.5 mM NH4HCO3 to prepare the working solution. This working solution was 
then incubated for 15 min at 37°C. ORP was incubated with equal volume of 
working trypsin solution for 3 hours at 37°C and mixed with TPCK solution after 
incubation. This ORP was now used as non-phosphorylated control. 
 
 
ORP Pull Down  
 
Caco-2 cells in T75 flask were grown to confluence. Cells were washed in ice-
cold PBS and extracted in lysis buffer (0.2% Triton X-100 in PBS containing 10 mM 
sodium fluoride, 1mM sodium pyrophosphate, 1 mM sodium ortho vanadate, 1mM 
PMSF and protease inhibitor cocktail (10 µl/ml). 1ml of extract was added to each of the 
non-phosphorylated, tyrosine phosphorylated and threonine phosphorylated ORP 
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triplicates. These mixtures were then incubated overnight at 4°C on rocker. 50 µl of 
streptavidin-Agarose (prewashed in cold PBS) was added to each sample and incubated 
for 1 hour at 4°C on rocker. The beads were centrifuged, washed and subjected to LC-
MS/MS analysis. 
 
 
LC-MS/MS Analysis 
 
 
Sample Workup  
 
Sample bead pellets (3) were suspended in 100 µl Tris-HCl (500 mM, pH 8.5), 
CaCl2 (100 mM). The samples were centrifuged for 2 minutes at 10,000 x g and the 
supernatant was recovered. This process was repeated one more time. The combined 
supernatant was treated with 5 µl of the reducing reagent dithiothreitol (DTT, 1 M in 
dH2O) and incubated at 37 oC for 30 min.  The reduced samples were incubated with 5 µl 
of the cysteine alkylating reagent iodoacetamide (IAA, 2.2 M in dH2O) for 15 min at 
room temperature, in the dark. After alkylation, a second aliquot of DTT was added (5 µl, 
1 M in dH2O) to neutralize excess IAA.  
 
Following reduction and alkylation, 5 µl of sequencing grade trypsin (1 µg/µl) 
were added and the samples were digested at 37 oC overnight. After digestion each 
sample volume was reduced by speed vacuum centrifugation to about 20 µl. Trypsin was 
neutralized by addition of 3 µl of neat trifluoro acetic acid (TFA). The peptides were 
purified with ZipTip C18 (Millipore) using procedures recommended by the 
manufacturer. The peptides bound to the C18 column were eluted with 4 µL of 50% 
acetonitrile/50% water/0.1% TFA. Two ZipTips per sample were used, and elution was 
performed with the same 4 µL-aliquot. After purification, the samples were diluted with 8 
µL of water/0.5% formic acid. 
 
 
LC-MS/MS 
 
The LC-MS/MS analyses were performed with an LTQ linear ion trap mass 
spectrometer (Thermo Scientific) interfaced with a Famos/Ultimate nanoflow LC system 
(Dionex). Two microliters of peptide digests were manually injected onto a nano injector. 
Peptides were separated on a home-packed capillary column (100 mm × 75 µm I.D.) 
packed with reversed phase C18 silica (5 µm, 200 Å). The peptides were eluted at a flow 
rate of 300 nL/min with a 95 min linear gradient from solvent A 
[(H2O:CH3OH:HCOOH), (97.9:2:0.1), v:v:v] to solvent B [(H2O:CH3OH:HCOOH), 
(9.9:90:0.1), v:v:v]. The mass spectrometer was operated in a data-dependent scan mode, 
where a survey MS scan (400–2000 m/z) was followed by MS/MS of the seven most 
intense precursor ions with dynamic exclusion on. 
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Peptide Data Analysis 
 
The raw data were input into Proteome Discoverer version 1.4 and searched with 
Sequest HT against a human database in silico digested with trypsin. The search 
parameters were: full tryptic specificity, precursor error tolerance 1.5 Da, product ion 
tolerance 0.8 Da. Allowed peptide modifications were carbamidomethylation of cysteine 
(static modification), and methionine oxidation and lysine acetylation (dynamic 
modifications). To calculate the false discovery rate for matched peptides, the same rat 
reversed database was used as a decoy and the resulting data were statistically analyzed 
by Percolator, a new standard component of Proteome Discoverer. Only peptides with 
PEP scores of 0.01 or lower were considered as positive matches. 
 
 
Protein Differential Expression Analysis 
 
The data from the Proteome Discover search results were further analyzed with 
the Scaffold software. Scaffold performs advanced processing of MS/MS data, spectral 
counting, and comprehensive data management. Scaffold uses statistical algorithms to 
validate search results and accepts peptide and protein identifications established at ≥95% 
probability. T-test statistics was used to identify differentially expressed proteins (p ≤ 
0.05). 
 
 
ORP and GST-Ocl-C Pull Down for MAP7 
 
 
ORP/ORPscr Tyrosine Phosphorylation  
 
ORP and ORPscr (0.5mM) were incubated with 0.5ug active c-Src in tyrosine 
kinase buffer (50 mm HEPES, pH 7.4, 1 mm EDTA, 0.2% β-mercaptoethanol, 3 mm 
MgCl2) containing 100 µm ATP at 30 °C for 3 hr on a shaking incubator. These samples 
were referred to as pY(tyrosine phosphorylated) forms of ORP and ORPscr. Samples 
from similar reactions performed in the absence of ATP were referred to as NP (non-
phosphorylated) forms of ORP and ORPscr. 
 
 
GST-Ocl-C/GST Tyrosine Phosphorylation 
 
Recombinant GST-Ocl-C (20 µg) and equimolar amount of GST (~10 µg) were 
incubated with 0.5ug active c-Src in tyrosine kinase buffer (50 mm Hepes, pH 7.4, 1 mm 
EDTA, 0.2% β-mercaptoethanol, 3 mm MgCl2) containing 100 µm ATP at 30 °C for 3 hr 
on a shaking incubator.  These samples were referred to as pY (tyrosine phosphorylated) 
forms of GST-Ocl-C and GST. Samples from similar reactions performed in the absence 
of ATP were referred to as NP (non-phosphorylated) forms of GST-Ocl-C and GST. 
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Pull Down  
 
Caco-2 cell extracts were prepared in lysis buffer (0.2% Triton X-100 in PBS 
containing 10 mM sodium fluoride, 1mM sodium pyrophosphate, 1 mM sodium ortho 
vanadate, 1mM PMSF and protease inhibitor cocktail (10 µl/ml). ORP-NP, ORP-pY, 
ORPscr-NP, ORPscr-pY, GST-Ocl-C-NP, GST-Ocl-C-pY, GST-NP, GST-pY were 
incubated with 1ml of cell extract overnight at 4 °C on a n inverter. 30 µl of pre-washed 
streptavidin agarose or GSH-agarose beads were added to each sample and incubated at 4 
°C for 1 hr. The beads were collected by centrifugation, washed and mixed with sample 
buffer. The beads were heated at 100 °C for 10 min and supernatant was collected by 
centrifugation. The samples were run on 7% tris-acetate gel and immunoblotted for 
MAP-7. 
 
 
Co-immunoprecipitation: Occludin/MAP7 
 
Caco-2 cell monolayers in 60 mm culture dishes were treated with 3% DSS or 
0.35M mannitol in DMEM for 3 hr. The cells were washed with ice-cold PBS and 
proteins were extracted in the IP buffer (50 mM Tris buffer, pH 7.4, containing 1% 
NP40, 2 mM EDTA, 2 mM EGTA, 10 mM sodium fluoride, 1 mM vanadate and protease 
inhibitor cocktail(10 µg/ml)). Protein concentration was estimated by BCA method. 1mg 
protein lysates were incubated with 2 µg monoclonal anti-occludin antibody at 4°C 
overnight on an inverter. Immune complexes were collected by precipitation using 
protein-A/G plus agarose beads and incubation at 4°C for 1hr. The beads were pelleted, 
washed, resuspended in sample buffer and heated at 100°C for 10 min to extract the 
bound protein. Samples were run on 7% tris acetate gel and immunoblotted for MAP-7.  
 
 
Colocalization Analysis: Occludin/MAP7 
 
Animal studies were performed according to an IACUC approved protocol. 
C57BL/6 mice (12 weeks old) were subjected to radiation (4 Gy). 2 hr post radiation, 
colon was harvested from the mice. Cryosections of the colon were prepared and fixed in 
acetone:methanol mixture. The fixed tissue sections were immunostained for occludin 
and MAP-7. Images were collected by confocal microscopy.  
 
 
Sources of Materials 
 
 
Antibodies 
 
Rabbit polyclonal anti-ZO-1, mouse monoclonal anti-occludin & anti-claudin 2, 
Alexa Fluor 488-conjugated anti-mouse IgG & phalloidin were purchased from 
Invitrogen (Carlsbad, CA). Mouse monoclonal anti-GFP antibody was purchased from 
Clontech (Mountain view, CA). Hoechst 33342 were obtained from Life technologies 
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(Carlsbad, CA). Mouse monoclonal anti-E-Cadherin and rabbit polyclonal anti-b-catenin 
were purchased from BD Biosciences (San Jose, CA). Rabbit polyclonal anti-MAP7, 
anti-plakophilin-3, rabbit monoclonal anti-peroxiredoxin 1 and mouse monoclonal anti-
HSP60 were obtained from EMD Millipore (Bedford, MA). Cy3-conjugated anti-rabbit 
IgG, HRP-conjugated anti-mouse IgG, HRP-conjugated anti-rabbit IgG, and mouse anti-
β-actin antibodies were obtained from Sigma (St Louis, MO). GFP-Trap_A was 
purchased from Chromotek (Hauppauge, NY). Restriction enzymes, T4 DNA ligase, 
polynucleotide kinase and DPn1 were obtained from New England Biolabs (Beverly, 
MA).  
 
 
Chemicals 
 
 Dulbecco’s minimum essential media (DMEM), fetal bovine serum (FBS) and 
antibiotics were purchased from Cellgro (Manassas, VA) while Calcium free DMEM 
was from Thermo Fisher Scientific (Tustin, CA.). Cytochalasin-D and genistein were 
obtained from Sigma Aldrich (St. Louis, MO). FITC-inulin, protease inhibitor cocktail, 
phenylmethylsulfonyl fluoride, Triton-X-100, streptavidin-agarose, GSH-agarose and 
IPTG were purchased from Sigma (St. Louis, MO). Protein A/G plus beads were 
obtained from Santa Cruz (Dallas, TX). All other chemicals were purchased from Sigma 
or Fisher. 
 
 
Statistical Analysis  
 
All data are expressed as Mean ± SEM. The differences among multiple groups 
were first analyzed by ANOVA.  When a statistical significance was detected, Tukey's t 
test was used to determine the statistical significance between multiple testing groups and 
the corresponding control.  Statistical significance was established at 95%. 
 
Data containing confocal images was collected from experiments repeated at least 
three times. Images were collected from at least three different locations of a stained 
monolayer and the best representative image was selected for the figures. Fluorescence 
intensity at the intercellular junctions was quantitated using Image J by selecting 20 
random ROIs from one image. Statistical analysis was performed by using ANOVA. 
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CHAPTER 3.    RESULTS 
 
 
Specific Aim 1: To Determine That ORM Confers Dynamics to TJ in a 
Phosphorylation-dependent Mechanism 
 
 
Generation of OclDM 
 
It is evident from a significant body of literature that ORM is an active site for 
phosphorylation. In order to determine the functional significance of ORM and occludin 
in TJ dynamics and regulation, a deletion mutant of occludin that lacks ORM was 
generated in a pEGFP plasmid containing human occludin gene (Figure 3-1A). 
Restriction digestion, PCR amplification and DNA sequencing confirmed the deletion of 
ORM (Figure 3-1B).  
 
Although ORM corresponds to 11 amino acids (Y398-S408), a larger deletion 
was designed to include the highly conserved region on either side of ORM (Figure 3-
1C). This resulted in a truncated occludin (OclDM), which lacks 28 amino acids (G388-
D415) compared to OclWT (Figure 3-1D). The ultimate goal was to perform truncation 
analysis of ORM to identify the residues that are essential enough to confer dynamic 
properties to TJ and occludin itself. 
 
 
Deletion of ORM Does Not Prevent Occludin Assembly at the TJ 
 
C-terminus of occludin is known to be required for the assembly and function of 
TJ barrier (82). First we examined whether ORM is required for occludin localization at 
TJ. To avoid potential interactions with endogenous occludin, occludin-deficient MDCK 
(OD-MDCK) cells were used. Stable clones expressing GFP-OclWT, GFP-OclDM or 
vector were generated and live imaging was performed to visualize GFP. At least 12 
clones were screened for fluorescence, of which 6 are reported here. 
 
In OclDM cells, GFP-occludin was localized at the TJ similar to that in OclWT 
cells, where as GFP was intracellular in vector-transfected cells (Figure 3-2A). There 
was no clonal difference as occludin localization was similar in all the clones screened 
(Figure 3-2B). This suggested that ORM is not required for occludin assembly at TJ. 
 
 
Absence of ORM in Occludin Does Not Prevent Its Interaction with ZO-1 
 
Occludin C-terminus comprises of a coiled-coil domain that interacts with ZO-1 
and this interaction is believed to be required for localization of occludin at TJ (18). First 
the expression of mutant occludin versus wild type was examined. Total protein was 
immunoblotted for occludin and GFP. Then to look at occludin/ZO-1 interaction, GFP 
was immunoprecipitated and immune complexes were blotted for ZO-1 and GFP. 
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Figure 3-1. Occludin Deletion Mutant That Lacks ORM (OclDM). 
 
A. pEGFP construct comprising of human occludin gene. ORM is located in the distal 
part of the sequence (Red). B. Double digestion of wild type and mutant constructs with 
BstXI and HpaI resulted in two fragments. The smaller fragment in case of mutant  
construct had a molecular weight lower than that in wild type construct confirming 
deletion of ORM. C. PCR amplification of the nucleotide sequence including ORM 
further confirmed the deletion of ORM. D. Schematic showing the location of ORM in 
occludin and the amino acid sequence of ORM. E. ORM deletion resulted in OclDM 
lacking the amino acid sequence from 388 to 415.  
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Figure 3-2. ORM Deletion Does Not Prevent Assembly of Occludin into TJ. 
 
A: OclWT, OclDM and Vec cell monolayers were imaged live for GFP fluorescence by 
confocal microscopy. B: Six clones of OclWT and OclDM cell monolayers were imaged 
live for GFP fluorescence using a 40X objective by epi-fluorescence microscopy. 
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Immunoblot for occludin showed the knockdown of endogenous occludin in all the 
clones. Immunoblot for GFP showed that GFP-OclDM has a molecular weight lower than 
GFP-OclWT, confirming the deletion (Figure 3-3A). Immunoprecipitation of GFP 
showed that GFP-OclDM interacts with occludin similar to wild type (Figure 3-3B) and 
the densitometry confirmed no significant difference in the amount of occludin pulled 
down with GFP (Figure 3-3C). This suggested that ORM is not required for interaction 
between occludin and ZO-1. 
 
 
Lack of Both ORM and Occludin Decreases Steady-state Resistance but Does Not 
Affect Leak Pathway Permeability 
 
To assess the effect of ORM deletion on barrier function, post-seeding barrier 
development was monitored by seeding cells on transwells. TER and unidirectional flux 
of FITC-inulin was measured everyday up to 4 days.  
 
Vector transfected cells developed low resistance on day-1, which did not change 
even after 4 days post-seeding. Re-expression of wild type occludin (OclWT) in OD cells 
increased steady state resistance from day-1 to day-4. However, the expression of mutant 
occludin showed no increase in TER (Figure 3-4A). On the other hand, although there 
was an initial difference in inulin-flux on day-1 & 2, inulin permeability was similar 
among these cells by day-4 (Figure 3-4B). This significant difference in TER with no 
apparent change in inulin flux that represents leak pathway, suggested that the 
permeability of ions or solutes smaller than inulin was altered in the absence of either 
ORM or occludin itself. 
 
 
Lack of ORM or Occludin Enhances Claudin-2 Expression at the TJ 
 
 To explain the differences in TER, we looked at the expression and distribution of 
claudin-2 which is a major cationic pore forming claudin (25). Confluent cell monolayers 
were fixed in acetone/methanol mixture and immunostained for claudin-2. Total protein 
extracts from the cells were immunoblotted for claudin-2. 
 
 A significant increase in claudin-2 localization at TJ was seen in cells expressing 
OclDM compared to that in OclWT cells (Figure 3-5A). This increase in claudin-2 was 
much more prominent in the absence of occludin as confirmed by a measure of claudin-2 
fluorescence intensity at the TJ (Figure 3-5B).  The immuoblot for claudin-2 showed an 
increase in claudin-2 expression in the absence of both ORM and occludin compared to 
wild type (Figure 3-5C) that was confirmed by densitometry (Figure 3-5D). These data 
support the observation that occludin plays a role in pore pathway permeability by 
regulating claudin-2 expression.  
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Figure 3-3. ORM Deletion in Occludin Does Not Prevent Interaction with ZO-1. 
 
A: Total protein extracts from OclWT, OclDM and Vec cells were immunoblotted for GFP, 
occludin and β-actin. B: GFP was immunoprecipitated from the native extracts of OclWT, 
OclDM and Vec cells and immunoblotted for ZO-1. C: Density of ZO-1 was measured and 
normalized to corresponding GFP band density. Values presented in the graph are mean ± 
sem (n = 3). Asterisk indicates that the value is significantly (p<0.05) different from 
corresponding OclWT value. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4. ORM Deletion Decreases Steady-state Resistance of the Barrier. 
 
A & B: Equal number of OclWT, OclDM and Vec cells were seeded onto transwell inserts.  
TER (A) and FITC-inulin flux (B) were measured at varying post-seeding times. Values 
presented in the graph are mean ± sem (n = 6).  Asterisks indicate the values that are 
significantly (p<0.05) different from corresponding values for OclWT group.  
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Figure 3-5.  Absence of Occludin or ORM Enhances Claudin-2 Localization at 
TJ. 
 
A & B: Fixed cell monolayers of OclWT, OclDM and Vec were immunostained for 
claudin-2 (green) (A) and fluorescence intensity at intercellular junctions was quantitated 
(B). C & D: Protein extracts were immunoblotted for claudin-2 and β-actin (C). Density 
of claudin-2 was measured and normalized to β-actin band density (D). Values presented 
in the graph are mean ± sem (n = 3). Asterisk indicates that the value is significantly 
(p<0.05) different from corresponding OclWT value.  
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Lack of Both ORM and Occludin Enhances Cytoskeletal Organization and 
Occludin Localization at TJ 
 
A non-ionic detergent based protein extraction is widely used to examine the shift 
of TJ components between the insoluble and soluble fractions during TJ assembly or 
disassembly. Most of the TJ components are pulled down along with the actin 
cytoskeleton-rich insoluble fraction. Since the mutant occludin appeared to be distinctly 
localized at TJ, we investigated whether there was any difference in the amount of 
occludin localization at TJ.  
 
The cells monolayers from day 1 and 3 post-seeding were fixed in 3% 
paraformaldehyde and double-labeled for actin and tubulin. Lysates from confluent cell 
monolayers were subjected to triton X-100 based lysis and centrifuged to isolate 
supernatant, which is referred to as Triton-soluble fraction. The pellet was resuspended 
and sonicated to obtain actin -rich fraction referred to as Triton-insoluble fraction. The 
lysates were immunoblotted for GFP and actin. 
 
Confocal microscopy showed that actin cytoskeleton was better organized at the 
intercellular junctions of OclDM and Vec cell monolayers compared to that in OclWT cell 
monolayers on day1. By day 3, cytoskeleton in OclWT appeared to have become well 
organized (Figure 3-6A). This suggested that the absence of either ORM or occludin 
enhanced cytoskeletal arrangement during barrier development. Immunoblot analysis of 
Triton-insoluble and soluble fractions indicated that both GFP- OclWT and GFP- OclDM 
were distributed in both fractions. In the triton-soluble fraction there was no significant 
difference in the amount of occludin in OclWT versus OclDM cells. However, in the triton-
insoluble fraction, the amount of occludin in OclDM cells was significantly higher 
compared to that in OclWT cells. Vector transfected cells that lack occludin acted as a 
negative control (Figure 3-6B). The densitometric analysis confirmed that GFP- OclDM 
association with the Triton-insoluble fraction was significantly higher that that of GFP-
OclWT (Figure 3-6C). This indicated that absence of ORM enhanced occludin association 
with actin rich fraction of cells.  
 
 
Deletion of ORM Reduces Occludin Mobility at the Intercellular Junctions 
 
 Because occludin localization at TJ was enhanced in ORM deletion mutant cells, 
we examined whether there was any difference in occludin mobility in the absence of 
ORM. Cells were grown to confluence and FRAP analysis was performed on day 3.  
Selected regions of interest (ROI) were defined at the intercellular junctions, bleached 
with laser at maximum power at 488nm. The module was set to capture images before 
and after the bleach. Fluorescence recovery was quantitated from the time series images 
and mobile fraction was calculated. 
 
 The time series images showed that the GFP-occludin fluorescence in OclWT cells 
recovered faster than that in OclDM cells (Figure 3-7A). Percent recovery fluorescence of 
OclDM  was significantly lower than that of OclWT (Figure 3-7B). The mobile fraction of  
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Figure 3-6. Deletion of ORM Enhances Association of Occludin with Actin-rich 
Fraction of Cells. 
 
A: Two days after seeding OclWT, OclDM and Vec cells were fixed and stained for F-actin 
(Green), β-tubulin (MT) (Red) and nucleus (Blue).  B & C: Triton-soluble and insoluble 
fractions prepared from OclWT, OclDM and Vec cells were immunoblotted for GFP and β-
actin (B).  GFP band densities were measured and normalized to corresponding β-actin 
band densities (C). Values are mean ± sem (n = 3).  Asterisks indicate the values that are 
significantly (P<0.05) different from corresponding value for OclWT cells. 
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Figure 3-7. ORM Deletion Reduced Mobile Fraction of Occludin. 
 
A & B: FRAP analysis of GFP in OclWT and OclDM cell monolayers. Time-lapsed images 
of ROI (region of interest) at intercellular junctions were collected before and after photo 
bleaching (A). Fluorescence intensity in the ROI was measured and plotted against time 
(B). Asterisks indicate the values that are significantly (P<0.05) different from 
corresponding value for OclWT cells. Percent mobile fractions of OclWT & OclDM were 
calculated (C). Values are mean ± sem (n = 8). Asterisk indicates the value that is 
significantly (P<0.05) different from corresponding value for OclWT cells. 
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deletion mutant occludin significantly reduced compared to the wild type (Figure 3-7C). 
This indicated that ORM is required for the mobility of occludin and that its ability to 
exchange with the non-tight junction pools is reduced in the absence of ORM.  
 
 
ORM Deletion Confers Resistance to Ca2+ Depletion-mediated Occludin 
Disassembly 
 
 In order to investigate the effect of ORM deletion on TJ dynamics, we performed 
Ca2+ switch assay in wild type and deletion mutant clones to look at the differences in TJ 
disassembly/ assembly. Confluent monolayers of clones expressing GFP-OclWT and  
GFP-OclDM were incubated in low calcium media (LCM) for 16 hr. Live images for GFP 
were captured before and after the incubation, by confocal microscopy. 
 
OclWT cells showed disassembly of wild type occludin from TJ as expected during 
Ca2+ depletion. Interestingly, deletion mutant occludin was not redistributed from TJ in 
OclDM cells (Figure 3-8). This resistance was evident in other clones as well, suggesting 
that ORM is required for mediating Ca2+ depletion-mediated occludin disassembly from 
TJ. 
 
 
ORM Deletion Confers Resistance to Ca2+ Depletion-mediated Barrier Dysfunction 
  
Ca2+ switch assay in cell monolayers grown on transwells is an important tool to 
understand barrier function during de novo TJ assembly and disassembly. Extracellular 
Ca2+ depletion induces TJ disruption, decrease in resistance and increase in permeability 
while Ca2+ restoration induces TJ assembly, increase in resistance and decrease in 
permeability. Here we assessed the effect of ORM deletion on barrier function during 
Ca2+ switch. Basal TER and inulin flux were recorded in cell monolayers in regular 
media (NCM). Cells were then incubated in LCM for 16 hr and resistance and flux of 
inulin was recorded. LCM was switched with NCM and barrier formation was monitored 
by measuring TER and inulin flux.  
 
 In OclWT cells, Ca2+ depletion-induced a decrease in TER and increase in inulin 
permeability, which returned to basal levels after Ca2+ restoration. However, in OclDM 
cells that lack ORM, and in Vec cells that lack occludin, there was no significant 
difference in TER (Figure 3-9A) and inulin flux (Figure 3-9B) after Ca2+ depletion 
compared to their basal values. This further confirmed that ORM is required for Ca2+ 
depletion-mediated barrier dysfunction. 
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Figure 3-8. ORM Deletion Attenuates Ca2+ Depletion-mediated Occudin Disassembly. 
 
Cell monolayers of OclWT and OclDM clones were incubated with LCM or NCM for 16 hours. Live-cell images for GFP fluorescence 
were collected before and after incubation by confocal microscopy. 
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Figure 3-9. ORM Deletion Attenuates Ca2+ Depletion-induced Barrier 
Dysfunction. 
 
A & B: OclWT and OclDM cell monolayers on transwell inserts were incubated with LCM 
for 16 hours followed by incubation with NCM for up to 3 hr.  TER (A) and FITC-inulin 
flux (B) were measured at varying times.  Values are mean ± sem (n = 6).  Asterisks 
indicate the values for OclWT cell monolayers that are significantly (p<0.05) different 
from corresponding values for OclDM and Vec cell monolayers. 
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Deletion of ORM Confers Resistance to Disruption of Apical Junctional Complex 
and Cytoskeleton 
 
Tight junctions and adherens junctions form key components of the apical 
junctional complex that are directly or indirectly connected to the actin cytoskeleton via 
scaffold proteins proteins and actin linkers.  Here we examined the effect of ORM 
deletion on Ca2+ depletion-mediated changes in the apical junctional complex. Confluent 
cell monolayers were incubated in LCM and fixed in 3% paraformaldehyde. The fixed 
monolayers were labeled for TJ components: GFP-occludin and ZO-1, AJ components: 
E-cadherin and b-catenin and cytoskeleton: actin and tubulin. 
 
Ca2+ depletion in OD-OclWT cells induced redistribution of occludin and ZO-1 
indicating TJ disruption (Figure 3-10A) as well as redistribution of E-Cadherin and b-
catenin indicating the disruption of AJ (Figure 3-10B). However, OD-OclDM cells were 
resistant to both TJ and AJ disruption. Ca2+ depletion also induced disassociation of actin 
and tubulin in OclWT but not in OclDM monolayers (Figure 3-10C). These results together 
confirmed that ORM is required for mediating Ca2+ depletion-induced disruption of TJ, 
AJ and cytoskeleton. 
 
 
ORM Deletion Attenuates TJ and AJ Disruption Induced by EGTA-based Ca2+ 
Depletion 
  
EGTA is a Ca2+ chelating agent widely used to deplete extracellular Ca2+ in 
calcium switch assay. Because OclDM cells were resistant to low Ca2+-mediated TJ 
disruption, we used EGTA to induce TJ disassembly. Confluent cell monolayers were 
exposed to 4mM EGTA and TER and inulin-flux were measured at varying time points. 
Fixed monolayers were labeled for GFP, ZO-1, E-cadherin and β-catenin. The images 
were collected using a confocal microscope. 
 
In OclWT cells, EGTA induced a decrease in TER by 5 min, which was delayed in 
the case of OclDM cells (Figure 3-11A). EGTA treatment led to an increase in inulin-flux 
in cells OclWT cells, which was significantly delayed in OclDM cells (Figure 3-11B). 
GFP-occludin and ZO-1 started to show disassembly as early as 5 min, which was 
prominent by 30 min. On the other hand, OclDM cells showed significant delay in 
occludin disassembly (Figure 3-11C). Similarly differences in AJ redistribution were 
observed (Figure 3-11D). These data confirmed that ORM deletion confers resistance to 
Ca2+depletion-mediated occludin disassembly. 
 
 
Deletion of ORM Does Not Prevent CytochalasinD-mediated Disruption of TJ and 
Barrier Dysfunction 
 
Disruption of actin cytoskeleton also disrupts TJ. To examine whether the 
resistance to TJ disruption in the absence of ORM was specific to Ca2+depletion, here we  
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Figure 3-10.  ORM Deletion Attenuates Ca2+ Depletion-mediated Disruption of 
Apical Junctional Complex and Cytoskeleton. 
 
A, B & C: OclWT and OclDM cell monolayers were incubated with LCM or NCM for 16 
hr. Fixed cell monolayers were stained for TJ proteins GFP-occludin (green) and ZO-1 
(red) (A), AJ proteins E-cadherin (green) and β-Catenin (red) (B) and cytoskeletal 
proteins F-actin (red) and β-tubulin (green) (C).  
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Figure 3-11. ORM Deletion Attenuates EGTA-mediated TJ and AJ Disruption. 
 
A & B: OclWT and OclDM cell monolayers on transwell inserts were incubated with 4 mM 
EGTA.  TER (A) and FITC-inulin flux (B) were measured at varying times. Values are 
mean ± sem (n = 6).  Asterisks indicate the values for OclWT cell monolayers that are 
significantly (p<0.05) different from corresponding values for OclDM and Vec cell 
monolayers. C & D: Cell monolayers fixed at varying times after EGTA administration 
were co-stained for GFP (Green) & ZO-1 (Red) (C) or E-cadherin (Green) & β-catenin 
(Red) (D). 
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employed another method to disrupt TJ. Confluent cell monolayers in transwells were 
treated with cytochalasin D (2 µg/ml ). Barrier function was assessed by measuring TER 
and inulin flux at various time points. Live imaging was also performed by exposing cells 
to cytochalasin D.  
 
Incubation of OclWT, OclDM and Vec cell monolayers with cytochalasin-D resulted 
in a drop in TER (Figure 3-12A) and increase in inulin-flux (Figure 3-12B). Live cell 
imaging of GFP fluorescence showed that cytochalasin-D induced disruption of occludin 
from the junctions in both OclWT and OclDM cell monolayers. All cells displayed 
characteristic appearance of discontinuous junctional occludin, typical of cytochalasin-D 
induced TJ disruption. These data together suggested that ORM is not required for 
mediating cytochalasin-D mediated barrier dysfunction. 
 
 
Deletion of ORM Does Not Prevent Osmotic Stress-mediated Disruption of TJ and 
Barrier Dysfunction 
 
Another method to disrupt TJ was employed to investigate the specificity of  
ORM deletion-induced resistance to Ca2+ depletion-mediated TJ disruption. Confluent 
cell monolayers in 60 mm dishes and 12 mm transwells were exposed to 600mOsM 
DMEM to induce osmotic stress. Barrier dysfunction was monitored by measuring TER 
and inulin-flux and live-cell imaging for GFP at varying time points. Fixed monolayers 
were stained for GFP and ZO-1 by immunofluorescence method. 
 
Exposure to osmotic stress induced increase in inulin permeability in OclWT, 
OclDM and Vec cell monolayers (Figure 3-13A) Live cell imaging for GFP showed 
osmotic stress-mediated junctional redistribution of GFP-occludin in both OclWT and 
OclDM cell monolayers (Figure 3-13B). Stain from fixed cell monolayers for GFP and 
ZO-1 indicated that osmotic stress induced redistribution of GFP-occludin and ZO-1 
from the intercellular junctions in both OclWT and OclDM cell monolayers (Figure 3-
13C). 
 
 
Phoshorylation of ORM on T403/403 and Y398/402 Determines Dynamic Properties 
of Occludin 
 
 Previous studies showed that the phosphorylation of threonine residues 
(T403/404) enhances TJ assembly while phosphorylation of tyrosine residues (Y398/402) 
negatively regulates TJ assembly. To investigate the role of ORM phosphorylation in 
occludin dynamics we generated OD-mutant clones expressing GFP-OclT403/404A, GFP-
OclT403/404D, GFP-OclY398/402A and GFP-OclY398/402D. Confluent cell monolayers were 
incubated in LCM and live images were captured at varying time points. FRAP analyses 
was performed in these cells to assess the role of ORM phosphorylation on occludin 
mobility.   
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Figure 3-12. ORM Deletion Does Not Prevent Cytochalasin-mediated TJ 
Disruption and Barrier Dysfunction. 
 
A & B: OclWT, OclDM and Vec cell monolayers on transwell inserts were incubated with 
Cytochalasin-D. TER (A) and FITC-inulin flux (B) were measured at varying times.  
Values are mean ± sem (n = 6). C: Live-cell images for GFP fluorescence were captured 
at varying times. 
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Figure 3-13. ORM Deletion Does Not Prevent Osmotic Stress-mediated TJ 
Disruption and Barrier Dysfunction. 
 
A: OclWT, OclDM and Vec cell monolayers were incubated with hyperosmotic medium 
and FITC-inulin flux was measured at varying times. Values are mean ± sem (n = 6). B: 
OclWT and OclDM cell monolayers were incubated with hyperosmotic medium (0.35M 
mannitol) and live images for GFP fluorescence were captured at varying times. C: Fixed 
cell monolayers were co-stained for GFP (Green) and ZO-1 (Red). 
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 Live cell imaging of GFP fluorescence showed that incubation with LCM for 24 
hr resulted in redistribution of GFP-OclT403/404D from the intercellular junctions similar to 
GFP-OclWT. However, redistribution of GFP-OclT403/404A was not altered with Ca2+  
depletion similar to that of GFP-OclDM. On the other hand, incubation with LCM induced 
partial redistribution of both GFP-OclY398/402D and GFP-OclY398/402A (Figure 3-14). These 
observations indicated that ORM contributes to occludin dynamics in a phosphorylation 
dependent mechanism. FRAP analysis demonstrated that the percent mobile fraction of 
GFP fluorescence OclT403/404D cell monolayers was similar to that of OclWT, whereas 
mobile fractions of OclDM, OclT403/404A, OclY398/402D and OclY398/402A were significantly 
low compared to that of OclWT cell monolayers (Figure 3-15). 
 
 
Phosphorylation of ORM on T403/403 and Y398/402 Determines Dynamic 
Properties of TJ 
 
 To investigate the role of ORM phosphorylation in TJ dynamics, mutant clones 
expressing GFP-OclDM, GFP-OclT403/404A, GFP-OclT403/404D, GFP-OclY398/402A and GFP-
OclY398/402D and wild type cells expressing GFP-OclWT were grown on transwells. 
Confluent cell monolayers were incubated in LCM and barrier function was assessed. 
Fixed monolayers at varying time points were labeled for GFP and ZO-1. 
 
 Measurement of TER in these cell lines showed that, incubation with LCM for 16 
hr results in a decrease in TER in OclWT and OclT403/404D cell monolayers; these effects are 
significantly greater compared to those in OclDM, OclT403/404A, OclY398/402D and OclY398/402A 
cell monolayers (Figure 3-16A). Inulin flux measurement, after 16 hr incubation with 
LCM showed increased inulin permeability in both OclWT and OclT403/404D cell 
monolayers. LCM-mediated inulin permeability was low in OclDM and OclT403/404A cell 
monolayers and moderate in OclY398/402D and OclY398/402A cell monolayers (Figure 3-16B). 
Immunofluorescent staining of fixed monolayers for GFP and ZO-1 showed that LCM 
induced redistribution of both occludin and ZO-1 from intercellular junctions in OclWT 
and OclT403/404D cell monolayers but not in OclDM and OclT403/404A cell monolayers.  
Ca2+ depletion had a significantly low effect on redistribution of occludin and ZO-1 in 
both OclY398/402D and OclY398/402A cell monolayers compared to that in OclWT cell 
monolayers (Figure 3-17). These data together suggested that ORM confers dynamic 
properties to TJ in a phosphorylation dependent mechanism. 
 
 
Tyrosine Phosphorylation Plays a Role in Ca2+ Depletion-mediated TJ Disruption 
 
Oxidative stress and osmotic stress mediated TJ disruption involves tyrosine 
phosphorylation of occludin on residues Y398 and Y402. However, very little is known 
about the role of tyrosine phosphorylation in Ca2+ switch assay. From the studies using 
mutation of tyrosine residues in ORM, it was clear that tyrosine phosphorylation is also 
involved in LCM-mediated TJ disruption. In order to further validate the role of tyrosine 
phosphorylation in Ca2+ depletion-mediated TJ disruption, MDCK cells grown on 
transwells were pretreated with either genistein or DMSO for 1hr. Cells were incubated  
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Figure 3-14. ORM Confers Dynamic Properties to Occludin in a Phosphorylation-
dependent Manner. 
 
OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and OclY398/402D cell monolayers were 
incubated with LCM for 24hr and in NCM for 2 hr. Live-cell images for GFP 
fluorescence were collected before and after incubation. 
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Figure 3-15. ORM Phosphorylation Determines Mobility of Occludin at TJ. 
 
FRAP analysis of GFP in OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and 
OclY398/402D cell monolayers.  Time-lapse images were collected before and after photo 
bleaching of ROI at intercellular junctions. Fluorescence intensity was measured and % 
mobile fraction was calculated.  
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Figure 3-16. ORM Determines Barrier Function in a Phosphorylation-dependent 
Mechanism. 
 
A & B: OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and OclY398/402D cell 
monolayers on transwell inserts were incubated with LCM for 16 hours. TER (A) and 
FITC-inulin flux (B) were measured at varying times.  Values are mean ± sem (n = 6).  
Asterisks indicate the values for OclWT cell monolayers that are significantly (p<0.05) 
different from corresponding values for OclDM and Vec cell monolayers. 
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Figure 3-17. ORM Confers Dynamic Properties to TJ in a Phosphorylation-dependent Mechanism. 
 
OclWT, OclDM, OclT403/404A, OclT403/404D, OclY398/402A and OclY398/402D cell monolayers were incubated with LCM for 16 hr. Cell 
monolayers fixed at 1 hr and 16 hr were stained for GFP (Green) and ZO-1 (Red). 
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in LCM and barrier function was monitored by measuring TER and inulin-flux. Cell 
monolayers fixed at varying time points were labeled for occludin and ZO-1. Incubation 
with LCM induced a decrease in TER (Figure 3-18A) and an increase in inulin-flux 
within 1 hr (Figure 3-18B), whereas treatment with genistein blocked the effect of LCM. 
Confocal images for occludin and ZO-1 showed that LCM induced redistribution of both 
occludin and ZO-1 from intercellular junctions into the intracellular compartment 
whereas cell monolayers treated with genistein were resistant to LCM-mediated 
redistribution of occludin and ZO-1 (Figure 3-18C). These data confirm that tyrosine 
phosphorylation plays a significant role in Ca2+ depletion-mediated TJ disruption. 
 
 
Specific Aim 2: To Determine That ORM-mediated Protein Interactions Are 
Involved in TJ Modulation 
 
 
ORP Permeability 
 
 In order to study the role of ORM in TJ modulation, we designed a synthetic 
peptide based on the occludin regulatory region. It has a biotin tag at its N-terminus and a 
TAT domain at its C-terminus. The biotin tag was intended to aid in the pull down 
assays, while the TAT sequence was added to aid in the permeation of ORP into cells. 
The peptide design is as shown in (Figure 3-19A). A scrambled peptide was used as a 
control.  
 
 First we investigated the permeation of ORP in Caco-2 cells. Confluent cell 
monolayers were treated with ORP. Fixed cell monolayers were immunostained for 
biotin and occludin. We then tested ORP permeability in mouse intestine. Isolated 
intestinal loops were injected with either saline or ORP and incubated for 1 hr. 
Cryosections were labeled for ZO-1, biotin and nucleus. 
 
 The confocal images of Caco-2 cell monolayers showed that ORP does permeate 
into the cells in a dose dependent manner, as seen by an increase in the intracellular Cy3-
streptavidin (Red), stained for biotin (Figure 3-19B). The images of intestinal loop 
injected with ORP showed a similar permeation of ORP into intestinal mucosa as seen by 
the stain for biotin (Red) (Figure 3-19C). These data together showed that ORP has the 
ability to permeate into cells. 
 
 
ORP Enhances TJ Assembly During Ca2+ Switch Assay in Caco-2 Cells 
 
The biological effect of ORP was examined in Caco-2 cells. Ca2+ switch assay 
was performed in confluent cell monolayers in the presence of the peptide. EGTA was 
used to deplete extracellular Ca2+ from the media and induce TJ disassembly. During 
recovery, ORP was added to normal Ca2+ containing media. Inulin flux was measured at 
varying time points. Cell monolayers fixed 1hr after calcium switch were double labeled 
for occludin and ZO-1.  
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Figure 3-18. Ca2+ Depletion-induced TJ Disruption Involves Tyrosine 
Phosphorylation.  
 
A & B: MDCK cell monolayers on transwells were treated with 100 µM genistein. TER 
(A) and FITC-inulin flux (B) were measured after 1 hr. C: Cell monolayers treated with 
genistein were fixed at 1hr after incubation in LCM and co-stained for GFP (Green) and 
ZO-1 (Red). 
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Figure 3-19. ORP Sequence and Its Permeability. 
 
A: ORP is comprised has an N-terminal biotin tag and a C-terminal TAT domain. 
ScrORP has a scrambled sequence. B: Confluent cell monolayers were treated with 3 µM 
and 10 µM ORP. Fixed cell monolayers were immunostained with anti-occludin antibody 
and Cy3-conjugated streptavidin. C: Isolated intestinal loops from C57BL/6 mice were 
injected with either saline or 10 µM ORP and incubated in DMEM at 370C for 1 hr. 
Cryosections of the loops were fixed and immunostained for ZO-1 (green), biotin (red) 
and nucleus (blue). 
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Ca2+ depletion-induced inulin permeability was seen to decline during Ca2+ 
switch-mediated recovery, indicating TJ assembly. This decrease in inulin-flux was 
enhanced by the presence of ORP in a dose-dependent manner (Figure 3-20A). Confocal 
images showed that ORP enhanced junctional assembly of occludin and ZO-1 in ORP 
treated monolayers compared to that of the control (Figure 3-20B). These observations 
indicated that ORP has the ability to mimic ORM based interactions required for TJ 
assembly. 
 
 
ORP Attenuates Radiation-induced Barrier Dysfunction and TJ Disruption 
 
In order to study the effect of ORP on barrier function, a radiation model was 
used. Confluent monolayers of Caco-2 cells in transwells were exposed to radiation (4 
Gy). The barrier function post-radiation was monitored by measuring flux of FITC-inulin 
and TER.  
 
To examine the effect of ORP on radiation induced barrier dysfunction, cells were 
pre-treated with ORP for 30 min and then exposed to radiation. TER and inulin-flux were 
measured. Cells were fixed at varying time points and immunostained for occludin, ZO-1 
and nucleus. 
 
Radiation induced a significant decrease in TER compared to the sham control 
(Figure 3-21A). There was a significant increase in inulin permeability in radiation 
treated cells compared to sham control (Figure 3-21B) indicating barrier dysfunction by 
radiation. However, when the cells were pre-incubated with ORP, 30 min prior to 
irradiation, barrier dysfunction was significantly attenuated compared to the scrambled 
control treatment as seen by relatively less drop in TER (Figure 3-21C) and decreased 
inulin flux  (Figure 3-21D). The confocal images showed that ORP treatment attenuated 
radiation-induced disassembly of occludin and ZO-1 from TJ (Figure 3-22). These data 
together suggested that ORP attenuates radiation-induced barrier disruption. 
 
 
ORP as a Bait 
 
In order to identify the proteins that interact with ORM, ORP that has a biotin tag 
at its N-terminus was used as bait in pull down assays. Incubation of recombinant GST 
tagged occludin C-terminus (GST-Ocl-C) with tyrosine kinase led to phosphorylation of 
tyrosine residues, as seen by an immunoblot for phospho tyrosine (33,34). Incubation of 
GST-Ocl-C with a serine/threonine kinase in vitro led to phosphorylation of threonine 
and serine residues and was evident from an immunoblot for phospho threonine and 
phospho serine (57).  
 
Similarly, ORP was pre-phosphorylated in vitro by incubation with either active 
c-Src or CK2 in presence of ATP to yield tyrosine phosphorylated ORP (ORP-pY) or 
threonine-phosphorylated ORP (ORP-pS/T) respectively. These phosphopeptides were 
incubated with native protein extracts from Caco-2 cells and biotin was pulled down  
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Figure 3-20. ORP Enhances TJ Assembly.  
 
Caco-2 cells seeded on transwells were treated with 4 mM EGTA. Following this, the 
media was switched with regular media containing either 3 & 10 µM ORP or scrambled 
control along with FITC-inulin (0.5 mg/ml). A. Inulin flux was measured for 6 hr during 
recovery. B. The monolayers were fixed 1 hr after Ca2+ switch and immunostained for 
occludin (Green) and ZO-1 (Red). 
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Figure 3-21. ORP Attenuates Radiation-induced Barrier Dysfunction. 
 
A & B: Confluent cell monolayers of Caco-2 cells in transwells were exposed to 
radiation (4 Gy). TER (A) and inulin-flux (B) were measured at varying time points. C & 
D: Cell monolayers were pre-treated with ORP for 30 min and then exposed to radiation 
(4 Gy). TER (C) and inulin-flux (D) were measured post-radiation.  
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Figure 3-22. ORP Attenuates Radiation-induced TJ Disruption. 
 
Cell monolayers pretreated with 10µM ORP were exposed to radiation (4Gy) and fixed at 
2 hr post-radiation. Monolayers were immunostained for occludin (Green), ZO-1 (Red) 
and nucleus (Blue).  
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using streptavidin agarose. The beads were isolated and subjected to LC-MS/MS 
analysis. By a bottom-up proteomics approach, the proteins pulled down in each sample 
were identified. Immunoblot analysis was performed for selective proteins. 
 
The proteins identified in each group were statistically analyzed and proteins were 
shortlisted based on the statistical scores (Table 3-1). Some proteins were pulled down 
by peptide irrespective of its phosphorylation status, like Peroxiredoxin 1 (PRDX1), 
where as some proteins pulled down were found exclusively in each group, like 
microtubule associated protein (MAP7). These data suggested that proteins interact with 
ORM in a phosphorylation-dependent mechanism. The ion spectra profiles of HSPD1, 
PRDX1, MAP7 and PKP3 peptides are provided in the figure (Figure 3-23).  
 
Immunoblot analyses was performed for PRDX1, Heat shock protein 60 
(HSPD1), Plakophilin 3 (PKP3) and MAP7. This confirmed interaction of native peptide 
with HSP 60 and PRDX1. On the other hand, immunoblot for MAP7 and plakophilin 3 
showed an enhanced interaction between tyrosine phosphorylated ORP and MAP7 as 
well as plakophilin3 (Figure 3-24). These data confirmed that ORP binds to proteins in a  
phosphorylation-dependent manner. 
 
 
MAP7 Binds to Tyrosine-Phosphorylated ORP and GST-Ocl-C 
 
 MAP7 is an epithelial specific microtubule associated protein known to be an 
essential cofactor for Kinesin-1 driven transport. Microtubule is believed to mediate acto-
myosin contraction and internalization of TJ proteins form junctions during Ca2+ 
depletion mediated TJ disruption. In order to validate the interaction between ORM and 
MAP7, both ORP and recombinant GST-Ocl-C were used. GST-Ocl-C comprises of the 
distal 150 amino acids of the occludin C-terminus. ORP and GST-Ocl-C were pre-
phosphorylated with c-Src in presence or absence of ATP and used as baits for the pull 
down assay using either streptavidin agarose or GSH agarose beads. ORPscr and GST 
were used as their respective controls. The protein complexes were immunoblotted for 
MAP7. 
 
 MAP7 was pulled down in case of ORP (NP) but not ORPscr. There was a 
significant increase in the amount of MAP7 pulled with ORP-pY, indicating that tyrosine 
phosphorylation enhances interaction between ORM and MAP7 (Figure 3-25A). 
Similarly, MAP7 was pulled down exclusively by GST-Ocl-C-pY (Figure 3-25B), 
suggesting that MAP7 interacts with tyrosine phosphorylated occludin C-terminus.  
 
 
DSS or Osmotic Stress Enhances Interaction Between Occludin and MAP7 
 
 In order to validate the interaction between full length occludin and MAP7, co-
immunoprecipitation analysis was performed in Caco-2 cells. Previous studies showed 
that both DSS and osmotic stress induce tyrosine phosphorylation of occludin (83,84). 
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Table 3-1. ORM-interacting Proteins Identified by LC-MS/MS. 
 
ORP (NP) 
(Total Proteins-78)  
ORP (pY) 
(Total Proteins-91)  
ORP (pS/T) 
(Total Proteins-85) 
Peroxiredoxin-1 (PRDX1) 
Acetyl CoA acetyltransferase 
Protein disulfide-isomerase A6 
Heat shock protein (HSPD1) 
Protein disisomerase A6 
ATP-citrate synthase 
Triose phosphate isomerase 
Glucose regulated protein 
Fatty acid synthase 
Thiamine transporter 1 
 
 
 
 
 
Ensconsin (MAP7) 
Plakophilin-3 (PKP3) 
Peroxiredoxin 1 (PRDX1) 
RNA helicase 
Tubulin beta-4 A 
Elongation factor 1a 
POU-domain binding protein 
Heat shock protein (HSPD1) 
Glutathione-S-transferase 
Glutathione peroxidase 
 
 
 
 
 
THO complex subunit 4 
Phosphate carrier protein 
RNA helicase 
Peroxiredoxin-1 
RNA binding protein EWS 
Glucose regulated protein 
Glutathione peroxidase-1 
Tubulin beta-4a 
Thiamine transporter 1 
Heat shock protein (HSPD1) 
 
Note: The table here enlists the statistically significant proteins (p ≤ 0.05) identified in pull down assay using non-phosphorylated 
ORP, tyrosine phosphorylated ORP (ORP-pY) and serine/threonine phosphorylated ORP (ORP-pS/T).  
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Figure 3-23. Ion Spectra Profiles of Peptides Corresponding to the Proteins 
Identified by LC-MS/MS. 
 
Represented here are the ion sprectra profiles of peptides corresponding to peroxiredoxin 
1(PRDX1), heat shock protein 60 (HSPD1), microtubule associated protein (MAP7) and 
plakophilin 3 (PKP3).  
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Figure 3-24. Immunoblot Analyses for Proteins Pulled Down by ORP. 
 
A: ORP or ORPscr in their native form were incubated with native cell extracts and 
subjected to pull down using streptavidin agarose. Protein complexes were 
immunoblotted for HSP60 and Peroxiredoxin1. B: Peptides were pre-phosphorylated 
with active c-Src (ORP-pY or ORPscr) and incubated with native cell extracts for the pull 
down. Protein complexes were immunoblotted for MAP7 and Plakophilin3. 
 
 
 
 
 
Figure 3-25. MAP7 Interacts with Tyrosine-phosphorylated ORP and Occludin C-
terminus. 
 
A & B: ORP and ORPscr (A) or GST and GST-Ocl-C (B) in their native form or pre-
phosphorylated with active-Src were incubated with Caco-2 cell extracts. Protein 
complexes were immunoblotted for MAP7 and GST.  
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Caco-2 cells were treated with either 3% DSS or osmotic stress. MAP7 was 
immunoprecipitated from the native cell extracts and immunoblotted for occludin and 
MAP7.  
  
 The immunoblot showed a minimal interaction between occludin and MAP7 in 
controls. However, this interaction was significantly enhanced by both DSS and osmotic 
stress (Figure 3-26A). The densitometric analysis confirmed that tyrosine 
phosphorylation enhanced interaction between occludin and MAP7 (Figure 3-26B). This 
suggested that MAP7 interacts with occludin in a tyrosine phosphorylation dependent 
mechanism. 
 
 
MAP7 Colocalizes with Occludin in Irradiated Mouse Colon  
 
 To validate the interaction between MAP7 and occludin in vivo, C57BL/6 mice 
were subjected to radiation (4Gy) and intestinal tissues were harvested after 2 hours. 
Cryosections of distal colon were fixed and immunostained for occludin and MAP7. 
High-resolution images were collected by confocal microscopy. 
 
 In the sham treated mouse colon, MAP7 had an intracellular distribution located 
near the perijunctional region. No colocalization of occludin and MAP7 was seen in the 
absence of radiation. However, MAP7 appeared to colocalize with occludin in irradiated 
mouse colon (Figure 3-27). These data suggested that radiation-induced tyrosine 
phosphorylation of occludin results in a potential interaction between occludin and 
MAP7. 
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Figure 3-26. MAP7 Interacts with Occludin in a Tyrosine phosphorylation-
dependent Mechanism. 
 
A: MAP7 was immunoprecipitated from cell extracts isolated from Caco-2 cells treated 
with either 0.35M mannitol or 3% DSS for 3 hr. Immune-complexes were blotted for 
MAP7 and occludin. B: Density of occludin was measured and normalized to 
corresponding MAP7 band density. Values presented in the graph are mean ± seem (n = 
3). Asterisk indicates that the value is significantly (p<0.05) different from corresponding 
control value. 
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Figure 3-27. MAP7 Colocalizes with Occludin in Radiation Exposed Mouse Colon. 
 
Mice (C57BL/6) were subjected to radiation (4Gy) and intestinal tissues were harvested 2 
hr. post-radiation. Cryosections of distal colon were fixed and labeled for occludin 
(Green) and MAP7 (Red). Images were collected by confocal microscopy. Inset shows 
zoomed-in regions of colocalization.  
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CHAPTER 4.    DISCUSSION 
 
 
Specific Aim 1: To Determine That ORM Confers Dynamics to TJ in a 
Phosphorylation-dependent Mechanism 
 
Occludin is considered as a functional component of TJ. The phosphorylation hot 
spot in occludin (ORM) is a potential regulatory platform that mediates phosphorylation-
dependent regulation of TJ. Several disorders have been shown to involve occludin 
redistribution from TJ with the associated increase in permeability and barrier 
dysfunction. Hence determining the function of ORM is crucial to understand TJ 
modulation both in the aspects of its physiology as well as disease pathogenesis.  
 
 
ORM Is Not Required for Assembly of Occludin into TJ 
 
Previous studies demonstrated that loss of occludin does not prevent TJ assembly, 
in both in vitro and in vivo models (35, 36). The intracellular transport of occludin is 
governed by its C-terminus (37). C-terminal sequence of ~150 amino acids (358-504) 
was believed to be required for occludin localization at TJ (14). However, Bald et al 
showed that C-terminally truncated chicken occludin localized at TJ in MDCK cells, 
although with a discontinuous distribution (85). A study by Chen et al using Xenopus 
embryos showed that C-terminally truncated mutant chicken occludin localized at TJ by 
its ability to oligomerize with endogenous occudin (38). In order to study the function of 
ORM, we first generated deletion mutant of occludin (OclDM) that lacks ORM. To avoid 
potential interactions with the endogenous occludin, we transfected OclDM into occludin 
deficient-MDCK cells and generated stable clones. As ORM is located in the C-terminus 
we examined whether the deletion of ORM affected the assembly of occludin into TJ. 
Consistent with the previous data, lack of ORM did not affect assembly of OclDM into TJ, 
indicating that ORM is not required for TJ assembly.  
 
The association of C-terminal sequence (358-504) with ZO-1 is required for 
occludin assembly at TJ (18). Structural analysis revealed that the distal C-terminal 
region (416-522) of occludin forms a coiled-coil structure that was sufficient for 
interaction with the guanylate kinase domain (GUK) of ZO-1 (31). Because ORM is 
located in close proximity with the coiled coil domain, we investigated if the interaction 
between occludin and ZO-1 was affected by deletion of ORM. Our studies showed that 
ZO-1 co-immunoprecipitated with GFP-OclDM similar to GFP-OclWT. This indicates that 
ORM is not required for the interaction between occludin and ZO-1. Based on these 
observations we concluded that ORM is not required for occludin assembly into 
intercellular junctions. 
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ORM Deletion Does Not Affect Barrier Development by Leak Pathway Flux 
 
Expression of both wild type and COOH-terminally truncated chicken occludin in 
MDCK cells induced an increase in TER, but only the truncated occludin expression 
induced an increase in paracellular permeability (40).  Another study demonstrated that 
knock down of occludin in MDCK cells altered paracellular ion permeability but not 
steady-state TER (86). To determine the effect of ORM deletion on barrier function, post 
seeding barrier development was assessed. Similar to OclWT, expression of OclDM showed 
a decrease in inulin permeability by day 4, indicating that the absence of ORM does not 
affect the barrier development. Interestingly, even on day 4 the resistance of OclDM and 
Vec cell monolayers remained lower than that in OclDM cell monolayers, although the 
inulin permeability was not different. This observation suggested that the pore pathway 
might be affected by ORM deletion, while leak pathway remains unaffected.  
 
 TER is a measure of the flux of all ions across the epithelium. Small ions do not 
discriminate between pore and leak pathways. A change in TER with unaltered leak 
pathway permeability implicated a change in pore pathway permeability. The expression 
of a subset of claudins that have the ability to form pores is known to determine 
paracellular permeability (87). In order to account for the differences in TER in these 
clones, we examined the expression and distribution of claudin-2, a major cationic pore 
forming claudin (25). A previous study has shown that S408 phosphorylation of occludin 
regulates claudin-2 localization in Caco-2 cell monolayers (27). Immunoblot analysis and 
confocal microscopy showed that claudin-2 levels and its junctional distribution were 
greater in OclDM and Vec cell monolayers compared to that of OclWT cell monolayers. 
Results indicated that the enhanced junctional localization of claudin-2 might have 
contributed to lower TER in these cell lines. These data suggest that barrier development 
in terms of TJ assembly at intercellular junctions is not affected by ORM deletion, 
however TJ regulation-mediated flux through pore pathway is affected in the absence of 
ORM. We showed for the first time that ORM might be involved in the regulation of pore 
pathway. 
 
 
ORM Deletion Enhances Occludin Localization and Reduces Its Mobility at the TJ 
 
The actin cytoskeleton is a dynamic network that maintains cellular architecture 
and tissue organization. Transmission electron microscopy and immunogold labeling 
studies revealed that a perijunctional actomyosin ring is located below the apical 
junctional complex (88,89). The cytoplasmic TJ plaque is closely associated with the 
cortical cytoskeleton via interactions with the scaffolding protein, ZO-1 (12). Early 
studies using pharmacological agents of disruption also revealed that the cytoskeleton 
plays an important role in regulating TJ permeability (88). It was implicated that 
cytoskeletal organization is important for maintenance of the TJ architecture and hence 
their sealing properties. Occludin C-terminus is known to interact with the actomyosin 
ring indirectly via its interaction with ZO-1(90). Here we examined the cytoskeletal 
organization of cells lacking ORM or occludin, during barrier development and the 
distribution of occludin between detergent soluble and detergent insoluble fractions. 
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Confocal microscopy showed that actin cytoskeleton was better organized at the 
intercellular junctions of OclDM and Vec cell monolayers compared to OclWT cell 
monolayers. Immunoblot analysis suggested that lack of ORM enhanced association of 
occudin with the actin rich triton insoluble fraction.  
 
Studies by Turner group have established the fact that TJ undergoes continuous 
remodeling at steady state. FRAP based studies by Shen et al (6) demonstrated that TJ 
proteins are highly dynamic and that they are in constant exchange with extra-junction 
pools. It was believed that it is through this plasticity of constant exchange with extra-
junction pools, TJ proteins respond to external and internal stimuli involved in 
paracellular barrier regulation. Each TJ protein has a distinct dynamic behavior. They 
showed that occludin was the most mobile among all the TJ proteins and exchanges by 
diffusion within and between TJ and lateral membrane. From our studies, FRAP analysis 
of the dynamic behavior of occludin showed that deletion of ORM makes occludin at the 
intercellular junctions, more static and less mobile. ORM may be required for this 
mobility of occludin. We believe that the increased association of OclDM with the actin 
cytoskeleton contributes to the reduced mobility. 
  
ORM Deletion Specifically Attenuates Ca2+ Depletion-mediated Disruption of 
Apical Junctional Complexes and Barrier Dysfunction 
 
 Ca2+ switch assay is a widely used technique to study de novo assembly of TJ, 
however the mechanism involved in Ca2+ depletion-mediated TJ disassembly or Ca2+ 
repletion-mediated TJ resassembly has not been identified. However, it is believed that 
the extracellular Ca2+ depletion-induced AJ disruption, as E-cadherin requires Ca2+ for its 
hemophilic interactions, leads to disruption of TJ. Another probable mechanism likely 
involved is that the depletion of extracellular Ca2+ leads to a decrease in intracellular 
Ca2+, which activates a signaling cascade that disassembles TJ and AJ components. 
ORM deletion attenuated Ca2+ depletion-induced TJ, AJ, cytoskeleton disruption and 
barrier function.  
 
The lack of an effect of LCM on junctional distribution of GFP-OclDM suggested 
that ORM is required for Ca2+ depletion -mediated redistribution of occludin. The lack of 
an effect of LCM on junctional distribution of ZO-1 in OclDM cell monolayers indicates 
that absence of ORM prevents disruption of TJ by Ca2+ depletion. Sustained junctional 
organization of E-cadherin and b-catenin in LCM-treated OclDM cell monolayers suggests 
that ORM deletion prevents disruption of AJ by Ca2+ depletion. Stability of actin 
cytoskeleton and microtubules in LCM treated OclDM cell monolayers demonstrates that 
lack of ORM blocks Ca2+ depletion -mediated reorganization of actin cytoskeleton and 
microtubules. Changes in TER and inulin flux by LCM and Ca2+ restoration indicates that 
barrier function is disrupted by Ca2+ depletion and restored by Ca2+ repletion in OclWT 
cell monolayers. Absence of such changes in TER and inulin-flux in OclDM and Vec 
monolayers, suggests that ORM is required for Ca2+ depletion mediated barrier 
dysfunction in MDCK cell monolayers. Similar results in experiments using EGTA 
mediated Ca2+ depletion model further confirmed the role of ORM in TJ and AJ 
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disruption. Thus ORM plays a likely role in mediating TJ assembly/disassembly during 
Ca2+ switch assay. 
 
Cytochalasin D is a well-known disruptor of the actin-cytoskeleton and disruption 
of actin cytoskeleton has been shown to disrupt epithelial TJ (91). Cytochalasin-D 
mediated decrease in TER, increase in inulin-flux and redistribution of occludin in both 
OclWT and OclDM cell monolayers suggests that ORM deletion does not affect 
cytochalasin D-mediated TJ disruption and barrier dysfunction. Similarly, data show that 
ORM deletion does not affect osmotic stress-mediated TJ disruption and barrier 
dysfunction. Mechanical disruption by cytochalasin-D and osmotic stress might have 
caused a drastic effect and irreversible damage to the TJ and hence the effect of ORM 
deletion on barrier function was not evident in these cases. 
 
 
Phosphorylation of ORM on T403/T404 and Y398/Y402 Determines the Dynamic 
Properties of TJ 
 
Previous studies in MDCK cells showed that expression of occludin with 
T403/404A mutation attenuated TJ assembly, while that with T403/404D mutation 
enhanced TJ assembly after Ca2+ switch (35). The results here show that T403/404A, but 
not T403/404D, mutation confers resistance to Ca2+ depletion-mediated redistribution of 
occludin and ZO-1 and barrier dysfunction, similar to ORM deletion mutation. This 
suggested that T403 and T404 phosphorylation of occludin is required for mediating Ca2+ 
depletion-mediated TJ disruption. Also T403/404A, but not T403/404D mutation reduces 
occludin mobility at the intercellular junctions similar to ORM deletion mutation. This 
suggested that T403 and T404 phosphorylation contributes to mobility of occludin at the 
intercellular junctions. In other words, the dynamic properties contributed by T403 and 
T404 phosphorylation enables internalization of occudin during TJ disassembly while its 
absence reduces mobile fraction of occludin and resists TJ disassembly by Ca2+ 
depletion. 
 
Previous studies showed that expression of occludin with Y398/402A mutation 
did not alter occludin localization at TJ during reassembly while that with Y398/402D 
mutation delayed TJ assembly after Ca2+ switch. From the current data, resistance to 
LCM-mediated barrier dysfunction and occludin/ZO-1 redistribution in the presence of 
genistein confirmed that tyrosine phosphorylation is involved in Ca2+ depletion-mediated 
TJ disruption. Y398/402A and Y398/402D mutations confer partial resistance to Ca2+ 
depletion-mediated redistribution of occludin/ZO-1 and TJ disruption, indicating that 
both tyrosine phosphorylation and dephosphorylation may be involved in Ca2+ depletion-
mediated TJ disruption. The decrease in mobility due to both Y398/402A and 
Y398/402D mutations suggested that tyrosine phosphorylation/dephosphorylation also 
confer dynamics to TJ. These data together demonstrate that ORM confers dynamics to 
TJ by a phosphorylation-dependent mechanism. 
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Specific Aim 2: To Determine That ORM-mediated Protein Interactions Are 
Involved in TJ Modulation 
 
We believed that the translation of occludin phosphorylation signal into TJ 
modulation, is mediated by proteins that interact with ORM. In order to further establish 
the significance of ORM phosphorylation in TJ modulation, the strategy employed was 
aimed to design a peptide that mimics ORM and investigate ORM-mediated protein 
interactions.  
 
 
ORP Enhances TJ Assembly and Barrier Function 
 
 Crystallography studies on occludin C-terminus determined that the distal part of 
this domain (416-522) forms a coiled-coil structure but the proximal region from 383-415 
does assume a secondary structure (31). Our data (unpublished) from studies on chicken 
occludin C-terminus using hydrogen deuterium exchange coupled mass spectrometry 
(HDE-MS) showed that there was significantly higher incorporation of deuterium in the 
peptide corresponding to ORM sequence. On the other hand, the residues Y398, Y402, 
T403, T404 and S408 are present as a cluster in a sequence, which is highly conserved 
among species (34,92). From this information, it was evident that ORM is an active site 
of phosphorylation that is readily available for ORM-mediated protein interactions.  
 
To identify the proteins that interact with ORM, a peptide analogous to ORM 
sequence (ORP) was designed with an N-terminus biotin tag and C-terminus TAT 
domain. Examination of ORP permeability in Caco2-cells and mouse colonic loops, 
showed increased uptake of ORP by the cells compared to that of the scrambled control. 
The idea was to have ORP mimicking endogenous ORM sequence. Then the biological 
effect of ORP was tested. Treatment with ORP enhanced TJ assembly and barrier 
function during Ca2+ switch. Balda et al, showed that Occludin C-terminus governs 
intracellular transport of occludin (85). This showed that the intracellular ORP might 
have enabled occludin transport to the TJ and enhanced barrier function. 
 
To further validate the biological effect of barrier function, a radiation model was 
used. Caco-2 cells when exposed to radiation showed a decrease in TER and increase in 
inulin-flux. However, when cells were pretreated with ORP, the radiation-induced 
decrease in TER, increase in flux and redistribution of occludin and ZO-1 was 
significantly attenuated. ORP was thought to attenuate radiation-induced barrier 
dysfunction by enhancing ORM-mediated protein interactions involved in maintaining TJ 
integrity. Thus far, the studies revealed that ORP has a potential to mimic endogenous 
ORM and positively regulate TJ. 
 
 
ORP Interacts with Proteins in a Phosphorylation-dependent Manner 
 
In order to identify the proteins that interact with ORM, ORP was used as bait in 
pull down assay coupled-mass spectrometry. ORM is differentially phosphorylated under 
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different physiological conditions. Tyrosine phosphorylation of occludin is associated 
with TJ disruption while threonine phosphorylation is involved in TJ assembly (36). To 
identify proteins that interact with differentially phosphorylated ORM, ORP was pre-
phosphorylated in vitro. Thus the method to phosphorylate in vitro was validated in our 
previous studies. The same principle was employed to selectively phosphorylate ORP 
either by incubation with c-Src, which is a tyrosine kinase, or CK2, which is a serine, 
threonine kinase. Three forms of ORP were used as baits in the pull down assay: ORP in 
its native form, tyrosine phosphorylated ORP (ORP-pY) and serine/threonine 
phosphorylated ORP (ORP-pS/T).  
 
Mass spectrometry of the pulled down samples was able to identify several 
proteins in each group. The protein hits were further analyzed using Scaffold software 
and statistically significant proteins were shortlisted. Some proteins were pulled down in 
all three groups while some were unique to each group indicating the phosphorylation 
dependent binding of proteins. I chose four proteins for further validation by immunoblot 
analyses. PRDX1 and HSPD1 were pulled down in all the three groups while MAP7 and 
PKP3 were pulled down exclusively by ORP-pY.  
 
PRDX1 is a protein with dual roles since it acts as a peroxidase and as a 
chaperone (93). PRDX1 is upregulated in human colorectal cancer and breast cancer 
(94,95), both the cases where occludin downregulation was reported (69,96). Although 
not much is known about role of PRDX1 in TJ, based on our pull down results it was 
speculated that PRDX1 interaction with ORM could have a potential role in chaperoning 
TJ proteins like occludin under physiological and pathophysiological conditions. PRDX1 
however was pulled down with ORP irrespective of its phosphorylation status. Another 
protein MAP7, which is a microtubule associated protein, was pulled down only by 
tyrosine phosphorylated ORP. Since tyrosine phosphorylation is associated with TJ 
disruption, an interaction between ORM and MAP7 indicated the existence of a potential 
mechanism mediating occludin trafficking during stress. Hence we focused on 
investigating the significance of the interaction between MAP7 and ORM. 
 
 
MAP7 Interacts with Occludin by a Phosphorylation-dependent Mechanism 
  
Because ORP is a synthetic peptide, it was essential to establish the interaction of 
MAP7 with occludin in its native form. First a recombinant occludin C-terminus tagged 
to GST was used to perform a pull down assay similar to that with ORP. Immunoblot 
analysis for MAP7 and GST revealed that MAP7 bound specifically to GST-Ocl-C-pY. 
This suggested that MAP7 directly interacts with occludin C-terminus, mediated by 
tyrosine phosphorylation.  
 
To further validate this interaction between full length occludin and MAP7, co-
immunoprecipitation analyses was carried out in Caco-2 cells. Since MAP7 binds to 
tyrosine-phosphorylated ORM, a stimulus that induced occludin phosphorylation was 
needed. Osmotic stress and DSS are known to induce JNK and c-Src mediated 
phosphorylation of occludin (83,84). Caco-2 cells were treated with either osmotic stress 
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or DSS and MAP7 was immunoprecipitated from the native extracts. Immunoblot 
analysis showed that although there was a basal amount of interaction between MAP7 
and occludin, this was significantly enhanced by treatment with both osmotic stress and 
DSS. This suggested that tyrosine phosphorylation of occludin enhances interaction with 
MAP7 possibly mediated by the activation of JNK and c-Src.  
 
Then I investigated the interaction between occludin and MAP7 in vivo. 
Radiation causes TJ remodeling by inducing oxidative stress (97). Occludin undergoes 
tyrosine phosphorylation during oxidative stress-induced disruption of TJ (52,53,98). 
Hence a radiation model was used to induce tyrosine phosphorylation of occludin in vivo. 
Mice were subjected to radiation and intestinal tissues were harvested 2 hr post radiation. 
Colonic cryosections immunostained for occludin and MAP7 showed marked differences 
between radiation treated and sham treated mice. Sites of occludin, MAP7 colocalization 
were observed in the radiation exposed mouse colon but not in the sham treated control. 
This suggested that MAP7 interacts with occludin which is tyrosine phosphorylated 
possibly by the oxidative stress induced by ionizing radiation. 
 
Ivanov et al., demonstrated that TJ disassembly is regulated by microtubules (99). 
TJ disruption involves microtubule-mediated contraction of actomyosin ring as well as 
microtubule-mediated internalization of TJ proteins. It was shown that Kinesin-1 is a 
motor protein that drives dynamic reorganization of microtubules and trafficking of TJ 
proteins. Kinesin-1 colocalizes with occludin at TJ as well as with occludin that was 
internalized by Ca2+ depletion (99). MAP7 is an epithelial specific microtubule associated 
protein and an essential cofactor for kinesin-1 (100,101). These observations suggested 
that MAP7 is the potential regulatory protein that in association with Kinesin-1 drives the 
trafficking of tyrosine-phosphorylated occludin during TJ disruption (Figure 4-1).  
 
 
Summary 
 
In conclusion, this series of studies determined the functional significance of 
ORM in TJ regulation. These studies identified that ORM plays an important role in 
mediating TJ assembly/disassembly during Ca2+ switch assay. The correlation between 
occludin phosphorylation and TJ modulation is further supported by the observation that 
ORM-mediated phosphorylation confers dynamic properties to TJ. They also shed light 
on the potential role of ORM in regulating pore pathway flux, which is mediated by pore-
forming claudins. MAP7, for the first time, has been identified as an ORM-interacting 
partner that mediates trafficking of occludin during TJ disruption. ORM is a highly 
dynamic site that recruits signaling molecules to modulate TJ, a mechanism most likely 
exploited during pathogenesis of several diseases associated with barrier dysfunction. 
The data here unravels novel mechanisms and associated proteins involved in TJ 
regulation that might prove to be potential therapeutic targets for TJ modulation. 
  
 83 
 
Figure 4-1. MAP7 Mediates Trafficking of Occludin During TJ Regulation. 
 
ORM is a site for phosphorylation dependent regulation of occludin. Tyrosine 
phosphorylation of occludin induces interaction with MAP7, which in association with 
kinesin-1 mediates dynamic regulation of occludin. Under pathological conditions such 
as radiation-induced oxidative stress, tyrosine kinase like c-Src is activated. Sustained 
phosphorylation of tyrosine residues in ORM enhances interaction with MAP7, which in 
association with kinesin-1and microtubule mediates internalization of occludin leading to 
TJ modulation. 
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